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Summary 
 
At the beginning of mammalian heart development a linear tube is established that is able to 
undergo peristaltic contractions to pump the blood from a posterior inflow to an anterior outflow 
region. Further development of this cardiac tube involves the recruitment of highly proliferative, 
undifferentiated precursor cells at both poles and the subsequent differentiation into 
cardiomyocytes to form the right ventricle, the outflow tract and the atria. The development of the 
cardiac venous pole region, which includes the myocardial sleeves of the caval veins inside the 
pericardial cavity and the sinoatrial node (SAN), depends on the further addition of yet another 
distinct mesenchymal cell population. These precursor cells are positive for the T-box 
transcription factor Tbx18, but do not express the cardiac transcription factor Nkx2-5. In Tbx18-
deficient embryos the development of the sinus venosus region is disturbed, the 
myocardialization of the sinus horns is delayed, the SAN is smaller, and the caval veins are 
positioned abnormal laterally inside the pleuropericardial membranes (PPMs), which are the 
precursors of the adult pericardium.  
My analysis of mice deficient for the transcription factor Wt1 revealed that the development of 
the sinus horns at the cardiac venous pole is coupled with that of the pericardium. A similar 
interdependence was detected in conditional beta-catenin loss- and gain-of-function mutant 
embryos suggesting that the release of the PPMs from the subcoelomic mesenchyme is 
essential for the development of a completely closed pericardium. This release depends both on 
Wt1 and its downstream effector retinoic acid, as well as on canonical Wnt/beta-catenin 
signaling. Defects in the detachment of the PPMs from the lateral body wall resulted in 
pericardial hernia, a phenotype that is also described as a rare congenital human disease. 
A second crucial process in the development of a complete pericardium is the closure of the 
pleuropericardial ducts (PPDs). These canals are necessary during early lung development, but 
they need to be closed for further pericardial development to occur correctly. In this work, I 
demonstrate the requirement of Tbx18 for the attachment of the PPMs to the hilus of the lung 
and thus for the closure of the PPDs. In Tbx18-deficient embryos these canals remain open and 
a pericardial hernia occurs. 
Furthermore, my analysis of conditional beta-catenin loss- and gain-of-function mutant embryos 
revealed the significance of canonical Wnt signaling for the myocardialization of the murine sinus 
horns. In the distinct Tbx18-positive, Nkx2-5-negative mesenchymal precursor cells of the sinus 
horns the canonical Wnt/beta-catenin signaling pathway is crucial for the maintenance of 
precursor cell proliferation.  
In summary, this work provides new insights into the development of the murine venous pole of 
the heart and reveals the interdependence between sinus horn and pericardial development. 
 
Keywords: murine heart development, pericardium, sinus horn  
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Zusammenfassung 
 
In Säugetieren entsteht am Anfang der Herzentwicklung ein einfacher linearer Schlauch, der 
peristaltische Kontraktionen ermöglicht und dadurch das Blut vom posterior gelegenen 
Einflussbereich zum anterioren Ausflussbereich pumpt. Die weitere Entwicklung des Herzens 
beruht auf der Rekrutierung von stark proliferierenden, undifferenzierten Vorläuferzellen an 
beiden Polen des Herzens sowie deren anschließende Differenzierung zu Herzmuskelzellen. 
Diese bilden den rechten Ventrikel, den Ausflussbereich und die Atrien. Die Entwicklung des 
venösen Pols des Herzens, welcher das Myokard der Hohlvenen innerhalb der Perikardhöhle 
und den sinoatrialen Knoten (SAN) beinhaltet, erfolgt durch die spätere Addition einer weiteren 
mesenchymalen Vorläuferzellpopulation. Diese Vorläuferzellen sind positiv für den T-Box-
Transkriptionsfaktor Tbx18, exprimieren aber nicht den kardialen Transkriptionsfaktor Nkx2-5. In 
Tbx18-Verlustmutanten ist die Entwicklung des Sinus venosus gestört, die Bildung des 
Myokards der Hohlvenen ist verzögert, der SAN ist verkleinert und die Hohlvenen sind abnormal 
innerhalb der Pleuroperikardmembranen (PPM), den Vorläufern des adulten Perikards, 
positioniert. 
Meine Untersuchung der Wt1-Verlustmutanten ergab, dass die Entwicklung der Sinushörner am 
venösen Pol des Herzens und des Perikards gekoppelt sind. Eine ähnliche gegenseitige 
Abhängigkeit wurde in konditionellen Beta-Catenin-Verlust- und Beta-Catenin-Stabilisierungs-
mutanten detektiert. Das deutet darauf hin, dass die Ablösung der PPM von dem 
subzölomischen Mesenchym für die Entwicklung eines geschlossenen Perikards notwendig ist. 
Diese Ablösung ist einerseits von Wt1 und einem nachgeordneten Retinsäure-Signalweg, 
andererseits vom kanonischen Wnt/Beta-Catenin-Signalweg abhängig. Defekte in der Ablösung 
der PPM von der seitlichen Körperwand resultieren in einer perikardialen Hernie, einer Öffnung 
zwischen der Pleurahöhle und der Perikardhöhle. Diese Missbildung ist auch als seltene 
angeborene Krankheit in Menschen beschrieben.  
Ein zweiter wichtiger Prozess bei der Entwicklung eines kompletten Perikards ist der Verschluss 
der pleuroperikardialen Kanäle (PPD). Diese Kanäle sind in der frühen Entwicklung der Lungen 
notwendig, müssen danach aber geschlossen werden, damit die Perikardentwicklung korrekt 
verläuft. In dieser Arbeit zeige ich, dass Tbx18 für die Anhaftung der PPM an den Lungenhilus 
und damit für den Verschluss der PPD notwendig ist. In Tbx18-Verlustmutanten bleiben diese 
Kanäle offen und eine perikardiale Hernie entsteht. 
Zusätzlich zu der Bedeutung des kanonischen Wnt Signalweges in der Perikardentwicklung 
weisen meine Analysen der konditionellen Beta-Catenin-Mutanten auch auf die Bedeutung des 
kanonischen Wnt-Signalweges für die Bildung der Herzmuskelzellen der Sinushörner hin. In der 
spezifischen Tbx18-positiven, Nkx2-5-negativen mesenchymalen Vorläuferzellpopulation der 
Sinushörner ist der kanonische Wnt-Signalweg für die Erhaltung der Proliferation der 
Vorläuferzellen notwendig.  
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Somit liefert die vorliegende Arbeit neue Erkenntnisse zur Entstehung des venösen Pols des 
Herzens und verdeutlich die gegenseitige Abhängigkeit der Entwicklung der Sinushörner und 
des Perikards. 
 
Schlagworte: Herzentwicklung, Maus, Perikard, Sinus Horn
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Introduction 
 
The heart is a highly complex and efficient muscle that will perform its function, the pumping of 
blood throughout the whole body, continuously during the complete life of its owner. It consists of 
two atria and two ventricles, which are separated by valves and septa (Figure 1). The superior 
and inferior caval veins receive the deoxygenated blood from the body and direct it into the right 
atrium, followed by the transport of the blood into the right ventricle. From here the blood is 
pumped through the pulmonary artery to the lungs. Afterwards the left atrium receives the 
oxygenated blood from the pulmonary veins, and conducts it to the left atrium that in turn pumps 
the blood through the aorta to the arterial circuit of the body.(1,2) 
 
 
Figure 1. Illustration of an adult human heart. The main components of a whole (A) or 
sectioned (B) heart are depicted. LA, left atrium; LV, left ventricle; RA, right atrium; RV, right 
ventricle; SAN, sinoatrial node; Modified from (2) 
 
To achieve an efficient blood transport, the heartbeat of the atria and ventricles is synchronized 
by the cardiac conduction system. Its main pacemaker is the sinoatrial node (SAN) that is 
positioned at the entrance of the superior caval vein into the right atrium. In combination with the 
right superior caval vein, the inferior caval vein, the persisting left caval vein (the coronary sinus 
in humans), and the sinus venarum, the SAN represents the systemic venous return of the 
murine heart.(3) 
 
The heart is a common focus of congenital malformations such as ventricular or atrial septal 
defects, sinus venosus interatrial communications, patent ductus arteriosus, transposition of the 
great arteries, or double-outlet right ventricle.(4) Cardiac malformations account for approximately 
30% of prenatal death, and congenital heart defects are the main cause for death in the first year 
after birth.(5,6) Furthermore, atrial arrhythmias in the systemic venous return of the heart often 
have their origin in genetic deficiencies during heart formation.(7) Therefore, embryonic cardiac 
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development has to be tightly regulated as marginal alterations may lead to severe congenital 
heart defects. In the last years the regulatory mechanisms involved in specification of cardiac 
lineages and cardiac morphogenesis have been studied extensively, but the genetic circuits 
regulating cardiac development are far from being completely understood. 
 
The formation of the embryonic cavities and cardiac development occur in parallel 
The heart is positioned inside the pericardial cavity, which is required for protection and 
positioning of the heart, throughout embryonic development and adult life. This pericardial cavity 
develops as part of the intraembryonic cavity, which arises between the somatic and splanchnic 
mesoderm by the gastrulation movements of the embryo (Figure 2 and Figure 3).(8,9)  
 
 
Figure 2. Formation of the intraembryonic cavity during human embryonic development. 
Transverse section trough different stages of human embryonic development (A aged 21 days, 
B in the middle of the 4th week, and C at the end of the 4th week) to clarify the establishment of 
the intraembryonic cavity. Modified from (8). 
 
The intraembryonic coelom is first divided into a peritoneal and a thoracic cavity by the ingrowth 
of the septum transversum, a thick mesenchymal tissue. This separation is not complete in the 
early human embryo, but two pericardioperitoneal ducts on each side of the foregut remain to 
allow the growth of the lung buds inside these canals (Figure 3). 
Introduction 
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Figure 3. Scheme of the intraembryonic coelom in the 4th week of human embryonic 
development. At this stage of development the intraembryonic coelom consists of the 
pericardial and peritoneal cavities, which are connected by the pericardioperitoneal ducts on 
both sides next to the foregut. Modified from (9). 
 
While the size of the lung increases, the pericardioperitoneal canals expand dorsally, laterally, 
and ventrally into the subcoelomic mesenchyme. During this process the laterodorsal 
mesenchyme next to the lung disappears and the pleural cavity expands inside the 
pericardioperitoneal ducts. Afterwards, the pericardial and pleural cavities are separated by the 
closure of the pleuropericardial duct and the formation of the pericardium, a double-walled 
mesothelial sac that completely surrounds the heart and the roots of the great vessels. 
Furthermore, the development of the diaphragm disconnects the pleural and peritoneal 
cavities.(8,10,11) These processes, especially the formation of the pericardium, are only partially 
analyzed in mice until now, and the genetic mechanisms regulating its development have 
remained unidentified.  
 
Cardiac development also starts during gastrulation, in the middle of the 3rd week in humans, 
and accordingly in mice at embryonic day (E) 6.5-7.5, by the migration of cardiac progenitor cells 
into the mesodermal layer of the embryo.(8,12) These cardiac progenitors are separated from the 
somatic mesoderm by the pericardial cavity (Figure 4A).(1) During further development the 
cardiac progenitor cells merge across the anterior midline and form the cardiac crescent around 
E7.75. The cardiac cells continue to move ventrocaudally to form a linear heart tube until E8.25, 
a process that is connected with the growth of the head folds and the ventral closure of the 
embryo (Figure 4B). The fully functional linear heart tube consists of two layers, the myocardium 
and the endocardium, and is connected to the foregut by the dorsal mesocardium. The wall of 
the thoracic cavity that surrounds the heart tube is named (embryonic) pericardium at this stage. 
Further development between E8.25 and E10.5 includes the addition of the epicardium to the 
heart, the elongation of the heart tube and a complex looping process inside the pericardial 
cavity, which results in a dorsocranial movement of the common atrium and the caval veins. 
Introduction 
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(Figure 4C). Additionally, the future chambers balloon out of the heart tube(13), and the 
separation of the chambers starts by the formation of endocardial cushions and the 
interventricular septum. Further remodeling results in the mature adult heart (Figure 4D).  
 
 
Figure 4. Schematic illustration of murine heart development. A – D, Illustration of different 
stages of cardiac development at E7.75 (A), E8.25 (B), E10.5 (C), and E12.5 (D). The upper row 
shows a whole embryo or an isolated heart, a representative section is depicted beneath. See 
main text for further information. avc, atrioventricular canal; avs, atrioventricular septum; ca, 
common atrium; cc, cardiac crescent; cp, cardiac progenitor; dm, dorsal mesocardium; dp, 
dorsal pericardium; e, endocardium; ec, endocardial cushion; ep, embryonic pericardium; fg, 
foregut; ht, heart tube; ift, inflow tract; ivs, interventricular septum; la, left atrium; lv, left ventricle; 
m, myocardium; pc, pericardial cavity; oft, outflow tract; ra, right atrium; rv, right ventricle; som, 
somatic mesoderm; tr, trabeculae. Modified from (1). 
 
Cardiac cells are derived from different precursor cell populations 
Two mesodermal progenitor pools contribute cells to the murine developing heart in a 
spatiotemporally specific manner, both express the cardiac transcription factor NK2 transcription 
factor related, locus 5 (Nkx2-5) (Figure 5).(14)  
The cardiac crescent derives from cells of the so-called first heart field (FHF) and encompasses 
mainly progenitor cells for the left ventricle and parts of the atria of the mature heart.(12) These 
cells are marked by an early differentiation into the cardiac lineage, a low proliferation rate, and 
the expression of heart and neural crest derivatives expressed transcript 1 (Hand1).(12) Precursor 
cells of the second heart field (SHF), which are positioned posterior and medially to the FHF 
cells, elongate the early heart tube by addition of progenitor cells on both the anterior (outflow) 
and the posterior (inflow) pole after E8.5. Therefore the SHF derived cells are the major 
contributor to the mature heart. Progenitor cells of the SHF are highly proliferative,(15) and remain 
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undifferentiated until they enter the growing heart. Recent findings revealed the existence of 
distinctive subpopulations inside the SHF that can be distinguished by gene expression profiles 
and their positioning next to the developing heart tube (Figure 5).(14)  
 
 
Figure 5. Two sources of mesodermal progenitor cells contribute to the developing heart 
from E7.5 to E10.5. The location and derivates of the first heart field (FHF) are shown in red, 
second heart field (SHF) derived structures are shown in green. Frontal views are depicted for 
E7.5 and E10.5, the elongation of the heart tube is displayed by lateral views at E8 and E8.5. 
LA, left atrium; LV, left ventricle; PA, primitive atria; OFT, outflow tract; RA, right atrium; RV, right 
ventricle. Modified from (12). 
 
The anterior subpopulation of the SHF contributes to the arterial pole of the heart that consists of 
the outflow tract with the pulmonary trunk and the aortic arches. The anterior SHF is marked by 
an expression of the fibroblast growth factor genes Fgf8 and Fgf10, and the T-box transcription 
factor Tbx1. Lately, the anterior heart field has been studied intensively, therefore a molecular 
network controlling its contribution to the arterial pole of the heart is emerging. Tbx1 supports 
proliferation of SHF progenitor cells and inhibits their differentiation into cardiomyocytes possibly 
by induction of Fgf8 expression.(16) The FGF and the bone morphogenetic protein (BMP) 
signaling pathways have opposing roles during SHF development. In the anterior heart field, 
FGF signaling pathway components (Fgf8 and Fgf10) induce progenitor cell proliferation and 
smooth muscle differentiation, whereas BMP signaling pathway components (Bmp2 and Bmp4) 
lead to the differentiation of progenitor cells into cardiomyocytes.(17,18)  
Cells of the posterior SHF contribute to the inflow region of the heart, and express the canonical 
Wnt signaling ligand wingless-related MMTV integration site 2 (Wnt2), but not the anterior SHF 
marker genes (Fgf8, Fgf10, Tbx1). The development of the atria and the atrioventricular canal 
thereby depends on a feed-forward loop by Wnt2 and GATA binding protein 6 (Gata6).(19) The 
canonical Wnt signaling pathway maintains SHF cells in an undifferentiated, proliferative state, 
and needs to be downregulated for myocardial differentiation in the entire SHF.(20)  
Canonical Wnt signaling requires the protein beta-catenin (Ctnnb1) as a signaling mediator. In 
the absence of Wnt signaling, the Ctnnb1 protein gets phosphorylated by a destruction complex 
and afterwards degraded by the proteasome. The binding of a Wnt ligand to a Frizzled (Fzd) 
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receptor results in the disassembly of the destruction complex, the Ctnnb1 protein is stabilized 
and translocates into the nucleus, where it activates transcription of target genes by interaction 
with TCF/LEF transcription factors. During heart development, Ctnnb1-mediated Wnt signaling 
has divergent effects, depending on the developmental context, and therefore needs to be tightly 
regulated in a spatiotemporal manner.(20)  
 
The myocardial sinus horns, the intrapericardial part of the caval veins, are not derived from the 
first or second heart fields, but they are added to the growing heart tube after the formation of 
atrial myocardium starting from E9.5.(21) Their mesenchymal precursor cells represent a distinct 
domain with a transcriptional network that is characterized by the absence of Nkx2-5 and 
specific T-box 18 (Tbx18) expression. The loss of Tbx18 results in a delayed myocardialization 
of the sinus horns, which are positioned abnormal laterally inside the pericardium.(21,22)  
Tbx18 belongs to a family of transcription factors that are characterized by its highly conserved 
DNA-binding domain, the T-box. In mammals six of the 17 known Tbx genes are crucial for 
embryonic heart development.(23) Tbx18 is also expressed in the proepicardial organ (PEO), a 
transitory mesothelial cell cluster at the posterior pole. Starting from E9.0, cells of the PEO 
adhere to the naked myocardium of the heart and form the epicardium. During the onset of 
development, some epicardial cells undergo epithelial mesenchymal transition and become 
epicardium-derived cells (EPDCs) that are crucial for the formation of cardiac fibroblasts, smooth 
muscle cells of the coronary vessels, and coronary endothelial cells.(24) Furthermore, Tbx18 and 
Tbx3 are expressed in the SAN. Absence of Tbx18 or Tbx3 results in a decreased SAN volume, 
but both Tbx genes act independently during SAN development. Tbx18 is crucial for the 
formation of the SAN head, whereas Tbx3 regulates differentiation into SAN myocytes.(25) Tbx18 
is also expressed in the interventricular septum and the left ventricular wall starting from 
E10.5,(26) but the importance of this Tbx18 expression domain remains to be deciphered. 
The molecular network regulating murine sinus horn development is poorly understood as only a 
few genes have been described therein additionally to Tbx18. Podoplanin (Pdpn) is specifically 
expressed in the Nkx2-5-negative mesenchyme and myocardium of the venous pole,(27) and in 
Pdpn-deficient mice the myocardium of the cardinal veins is hypoplastic and the cardinal veins 
are dilated.(28) Moreover, the homeodomain transcription factor short stature homeobox 2 
(Shox2) is expressed in the sinus horn myocardium, and required for the recruitment of this 
myocardium.(29)  
 
In addition to Tbx18, the PEO and the epicardium express the zinc finger transcription factor 
Wilms tumor 1 (Wt1).(30) Wt1 was first described as a tumor suppressor gene in the etiology of a 
pediatric kidney cancer (named Wilms tumor) that resulted from mutations inside the human 
WT1 gene. However, further studies in mice revealed the importance of Wt1 during embryonic 
organ formation, especially development of the genitourinary system and mesothelial tissues. 
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Wt1-deficient mice die around midgestation due to severe heart defects, and no kidneys are 
formed in these embryos.(31) Wt1 is expressed in all mesothelial tissues like the epicardium, 
pericardium, and the lining of the body cavities (pericardial, pleural, and peritoneal).(32) In 
general, mesothelial tissues can be distinguished in a visceral mesothelium, the lining of the 
internal organs (e.g. heart and lung), and a parietal mesothelium, which covers the body wall. 
Therefore, the epicardium can also be considered as visceral pericardium. It is separated from 
the (parietal) pericardium by the pericardial cavity that is filled with the serous pericardial fluid. 
This pericardial fluid is crucial for the smooth movement of the heart inside the pericardial 
cavity.(33)  
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Aim of this thesis 
 
The development of the heart mainly depends on the elongation of the early heart tube by 
addition of undifferentiated precursor cells, as most of the mature adult heart derives from the 
progenitor cells of the second heart field (see above). After the addition of the atria onto the 
growing heart tube, a third population of progenitor cells elongates the heart at the venous pole 
and forms the myocardial sleeves of the caval veins. At the beginning of my thesis, Christoffels 
et al. identified that these cells do not belong to the first or second heart field, but express the T-
box transcription factor Tbx18.(21) This finding implicated a distinct character of the sinus horn 
progenitor population. To obtain additional knowledge about the development of the sinus 
venosus region of the heart, the aim of my thesis was to further analyze the development of the 
venous pole and its mesothelial lining.  
Canonical Wnt/beta-catenin signaling is necessary for the maintenance of second heart field 
derived cells in a proliferative, undifferentiated state.(20) A similar mechanism may be crucial for 
the addition of sinus venosus precursor cells to the growing heart. For this reason, I wished to 
analyze conditional beta-catenin gain- and loss-of-function mutant mice for alterations in the 
formation of the sinus horns. Additional work was to focus on the morphological and molecular 
analysis of mutant mice as well as on lineage tracing experiments to define the contribution of 
both Wt1 and Tbx18 expressing cells to the developing sinus venosus region of the heart. 
Sinus horn development is coupled with the formation of the murine pericardium, but the cellular 
and molecular programs underlying the formation of this tissue were completely unknown at the 
beginning of my work. To gain more insights into pericardial development, wildtype and different 
mutant mice with pericardial defects were to be analyzed by histological and molecular means.  
Thus, this thesis focuses on the development of the posterior pole of the heart including the 
sinus horns and the pericardium. It reveals new insights into the cellular and molecular 
processes during the formation of this cardiac subregion.  
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Supplemental Online Materials and Methods 
 
 
Mice and genotyping 
In Wt1tTA knock-in mice, the coding sequence of an improved tetracycline-dependent 
transactivator tTA2S1 was introduced into the Wt1 locus by gene targeting (Lausch et al., 
manuscript in preparation). This exchanged exon 1 and 360 bp of 3’ downstream sequence of 
Wt1 for the coding sequence of tTA2S, substituting the Wt1 translational start site with the ATG 
of tTA2S. Expression of tTA2S under endogenous Wt1 control elements faithfully recapitulates 
the pattern of native Wt1, both in adult mice and during development. Heterozygous Wt1tTA 
knock-in mice are phenotypically normal, showing no anatomical or histopathological 
abnormalities up to an age of fifteen months. Wt1 tTA / tTA embryos, however, died prior to day 
E11.5 of gestation as described for Wt1 - / -  mice2. Administration of the tetracycline derivative 
doxycycline (which has a high affinity for tTA2S) to Wt1tTA mice at a concentration of 0.1 mg per 
ml drinking water was sufficient to stringently suppress transcription of tetracycline-responsive 
transgenes in all Wt1-positive tissues in vivo, as analyzed by qPCR, histochemistry, 
immunohistochemistry, and chemiluminescence. For fate mapping of Wt1-positive cells in situ, 
Wt1tTA knock-in mice were crossed with reporter strains carrying a tetObiLacZ-GFP transgene.3 
In double-transgenic animals maintained without doxycycline (-DOX), Wt1-controlled tTA2S 
drives expression of both the green fluorescence protein (GFP) and ß-galactosidase from a tTA-
responsive bidirectional promoter, composed of seven tet-repressor binding sites (TetO7) 
immediately upstream of an RNA polymerase II transcriptional start site of the cytomegalovirus 
immediate early promoter. For the generation of mutant embryos, heterozygous mice were 
intercrossed. For timed pregnancies, vaginal plugs were checked in the morning after mating, 
noon was taken as embryonic day (E) 0.5. Embryos were harvested in PBS, fixed in 4% 
paraformaldehyde overnight and stored in 100% methanol at –20oC before further use. Wildtype 
littermates were used as controls. Genomic DNA prepared from yolk sacs or tail biopsies was 
used for genotyping by PCR (protocols upon request). H. Hedrich, state head of the animal 
facility, approved the care of animals and experiments at Medizinische Hochschule Hannover. 
 
 
Food supply of retinoic acid 
Pregnant females were treated with retinoic acid (RA) to rescue venous pole development in 
Raldh2- and Wt1-deficient embryos similar to described protocols.4,5 All-trans-RA (Sigma) from a 
5 mg/ml ethanol stock suspension was diluted in 50 ml water and mixed with 50 g powdered 
food (irradiated PicoLab rodent diet 20) to a final concentration of 100 mg/g food. The RA-
containing food mixture was left in the cage for ad libitum feeding and renewed twice a day until 
the day of sacrifice.  
 
 
Histological analyses  
For histological stainings embryos were fixed in 4% paraformaldehyde, paraffin embedded, and 
sectioned to 5 or 10 µm. Sections were stained with haematoxylin and eosin, following standard 
procedures.  
 
 
In situ hybridization analysis  
In situ hybridization analysis with digoxigenin-labeled antisense riboprobes followed a published 
protocol.6 Details of used probes upon request. 
 
 
Immunohistochemistry 
For immunohistochemistry rabbit polyclonal antibody against Wt1 (C-19, Santa Cruz 
Biotechnology, 1:200), goat polyclonal antibody against Tbx18 (C-20, Santa Cruz Biotechnology, 
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1:200), monoclonal antibody against cardiac Troponin I (1:500 MAB1691, Millipore),7 and rabbit 
IgG fraction against β-Galactosidase (Cappel, 1:4000) were used as primary antibodies. 
Alexa488 goat-anti-rabbit (Invitrogen, 1:250) and biotinylated donkey-anti-goat (Dianova, 1:200) 
were used as secondary antibodies. Nuclei were stained with 4′,6-Diamidino-2-phenylindol 
(DAPI) (Roth) or Topro3 (Invitrogen). For staining with the Tbx18 antibody, paraffin sections 
were pressure cooked for 3 min in antigen unmasking solution (H-3300, Vector Laboratories 
Inc). The signal was amplified using the Tyramide Signal Amplification (TSA) system from 
Perkin-Elmer (NEL702001KT, Perkin Elmer LAS). For double staining with Wt1, Alexa488 goat-
anti-rabbit secondary antibody was added during the streptavidine-HRP step of the TSA 
protocol. For β-Galactosidase, the primary antibody was amplified using the VECTASTAIN ABC 
Kit (Peroxidase rabbit IgG, Vector Laboratories, PK-4001). The detection of this antibody was 
performed with the DAB Peroxidase Substrate Kit from Vector Laboratories (SK-4100). 
 
 
Documentation 
Sections were photographed using a Leica DM5000 microscope with Leica DFC300FX digital 
camera. Immunofluorescence for Wt1BAC-IRES-EGFPCre/+; R26lacZ/+ lineage tracing was detected 
using a Leica SPE confocal microscope. All images were processed in Adobe Photoshop CS. 
 
 
Three-dimensional reconstruction 
Three-dimensional visualization and geometry reconstruction of patterns of gene expression 
determined by in situ hybridization was performed as described previously.8 Shortly, serial 
sections were used for in situ hybridization and were documented as described. The remaining 
analysis was done with the help of the software “Amira” (Version 4.1.1, Mercury Computer 
Systems Inc). The pictures were aligned, and regions for reconstruction were labeled. After 
surface conversion a three-dimensional model was obtained.  
 
 
Proliferation and apoptosis assays  
Cell proliferation in the E11.5 and E12.5 embryos was investigated by detection of incorporated 
5-bromo-2-deoxyuridine (BrdU) on 5-µm sections of paraffin-embedded specimens similar to 
previously published protocols.9 Ten sections each of three embryos of each genotype at E11.5 
and 15 sections each of four embryos of each genotype at E12.5 were used for quantification. 
The BrdU-labeling index was defined as the number of BrdU-positive nuclei relative to the total 
number of nuclei, as detected by DAPI counterstain, in the Wt1 expressing region next to the 
cardinal veins. Statistical analyses were performed using the 2-tailed Student’s t-test. Data were 
expressed as mean ± SEM. Differences were considered significant when the P-value was 
below 0.05. 
Detection of apoptotic cells in 10-µm paraffin sections of E10.5 to E13.5 embryos was based on 
modification of genomic DNA utilizing terminal deoxynucleotidyl transferase (TUNEL assay) and 
indirect detection of positive cells by fluorescein-conjugated anti-Digoxigenin antibody. The 
procedure followed exactly the recommendation of the manufacturer (Serologicals Corp.) of the 
ApopTag kit used. Three sections each of two embryos of each genotype at E10.5, of three 
embryos of each genotype at E11.5, of four embryos of each genotype at E12.5 and of six 
wildtype and five Wt1-mutant embryos at E13.5 were analyzed. Additionally three sections of 
two RARE-LacZ embryos of E12.5 and E13.0 each were used. The detection of apoptotic cells 
in the Raldh2-deficient mice was performed with three embryos of each stage. Wildtype and 
Raldh2-deficient embryos were littermates and fed with retinoic acid from embryonic day E7 to 
E9. 
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Supplemental Online Figures 
 
 
 
 
Online Figure I. SAN morphology is changed in Wt1-deficient hearts. In situ hybridization 
analysis for sinoatrial node (SAN) expression of hyperpolarization-activated, cyclic nucleotide-
gated K+ 4 gene (Hcn4) in E12.5 hearts of wildtype (wt) and Wt1-deficient (Wt1-/-) embryos on 
transverse sections trough the base of the cardinal vein. rsh, right sinus horn; ra, right atrium; 
rcv, right common cardinal vein.  
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Online Figure II. Wt1-positive subcoelomic mesenchyme does not contribute to the sinus horns. 
Analysis of LacZ expression by in situ hybridization (A,C) and of ß-galactosidase protein (ß-Gal) 
by immunohistochemistry (B,D) in Wt1tTA x tetObiLacZ-GFP embryos at E12.5 and E14.5 on 
transverse sections through the cardiac venous pole. Black arrowheads point to the border of 
the LacZ expression between the Wt1-positive subcoelomic mesenchyme of the lateral body 
wall and the absence of LacZ expression in the myocardium of the sinus horns. rcv, right 
common cardinal vein; lcv, left common cardinal vein.  
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Online Figure III. No changes of marker gene expression for atrial, sinoatrial node (SAN) and 
sinus horn myocardium in Wt1-deficient hearts. In situ hybridization analysis was carried out on 
transverse sections of the venous pole region of E12.5 hearts of wildtype and Wt1-deficient 
embryos. Genotypes and probes are as indicated. Nkx2.5 (A,B) and Connexin40 (Cx40) (C,D) 
were confined to the atrial myocardium and were excluded from the myocardium of the sinus 
horns and the SAN. Expression of Tbx5 (E,F) and Gata4 (G,H) comprised the myocardium of 
the SAN in addition to that of the atria. Isl1 expression (I,J) was confined to the SAN 
myocardium. The expression domain of Tbx18 (K,L) comprised the epicardium and pericardium, 
the myocardium of the sinus horns and the SAN. Shox2 (M,N) is found in the SAN myocardium 
and the venous valves, similar to bone morphogenetic protein 4 (Bmp4) (O,P) that however 
appeared patchier in its expression. Asterisks in (A) mark the subcoelomic lateral body wall 
mesenchyme. dm, dorsal mesocardium; la, left atrium; lcv, left common cardinal vein; ra, right 
atrium; rcv, right common cardinal vein.  
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Online Figure IV. Wt1 and Raldh2 are coexpressed in epicardium, pericardium and 
subcoelomic mesenchyme of the lateral body wall during heart development. In situ hybridization 
analysis of Wt1 and Raldh2 gene expression carried out on transverse sections of wildtype 
embryos from E11.5 to E14.5 on different section planes. Probes and stages are as indicated. A-
D’, expression of Wt1 and Raldh2 at the posterior part of the pericardial cavity; E-H’, expression 
of Wt1 and Raldh2 at the venous pole region; I-L’, expression of Wt1 and Raldh2 at the anterior 
part of the pericardial cavity. icv, inferior cardinal vein; lu, lung; li, liver; la, left atrium; lv, left 
ventricle; lcv, left common cardinal vein; lsh, left sinus horn; pc, pericardial cavity; ppm, 
pleuropericardial membrane; ra, right atrium; rv, right ventricle; rcv, right common cardinal vein; 
rsh, right sinus horn. 
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Online Figure V. Markers for the subcoelomic mesenchyme of the lateral body wall are 
unchanged in Tbx18-deficient embryos. In situ hybridization analysis of marker gene expression 
carried out on transverse sections of the venous pole region of E12.5 hearts of wildtype and 
Tbx18-/- embryos. Genotypes and probes are as indicated. Asterisks in (A) mark the 
subcoelomic lateral body wall mesenchyme. dm, dorsal mesocardium; la, left atrium; lcv, left 
common cardinal vein; ra, right atrium; rcv, right common cardinal vein.  
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Online Figure VI. Markers for the subcoelomic mesenchyme of the lateral body wall are 
unchanged in Raldh2-deficient embryos. In situ hybridization analysis of marker gene expression 
carried out on transverse sections of the venous pole region of E12.5 hearts of wildtype and 
Raldh2-/- embryos food supplied with RA between E7 and E9 (RA E7-9). Genotypes and probes 
are as indicated. Asterisks in (A) mark the subcoelomic lateral body wall mesenchyme. dm, 
dorsal mesocardium; la, left atrium; lcv, left common cardinal vein; ra, right atrium; rcv, right 
common cardinal vein.  
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Online Figure VII. Absence of apoptotic cell clusters in the lateral body wall mesenchyme of 
Raldh2-deficient embryos. Analysis of apoptosis in the Wt1-positive subcoelomic mesenchyme 
on transverse sections trough the venous pole in wildtype and Raldh2-deficient embryos food 
supplied with RA between E7 and E9 (RA E7-E9) by TUNEL staining. Dorsal is oriented up. 
Stages and genotypes are as indicated. Asterisks in (A) mark the subcoelomic lateral body wall 
mesenchyme. The white arrow (B) points to the cluster of apoptotic cells in E13.5 wildtype 
embryos.  rcv, right common cardinal vein; ra, right atrium; lcv, left common cardinal vein; la, left 
atrium; ppm, pleuropericardial membrane.  
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Online Figure VIII. Exogenous retinoic acid (RA) does not rescue Raldh2-deficiency in venous 
pole development after E9.5. Histological, molecular and morphological analyses of sinus horns 
(A-H,M,N) and the sinoatrial node (I-L) were carried out on transverse sections of the venous 
pole region of E14.5 wildtype, Wt1- and Raldh2-deficient embryos food supplied with RA 
between E7 and E14 (RA E7-14). A-H,M-N, Histological stainings with haematoxylin and eosin 
(A-D), in situ hybridization analysis of cTnI expression (E-H), and 3D-reconstructions of serial 
sections stained for cTnI in a dorsal-posterior view. Atrial myocardium is shown in green, 
cardinal vein myocardium in grey, the lumen of the cardinal veins in brown, and the pulmonary 
vein myocardium in red (M,N). Asterisks in B,D,F,H mark persisting subcoelomic mesenchyme. 
I-L, in situ hybridization analyses of sections through the base of the cardinal veins for 
expression of marker genes for the sinoatrial node with probes as indicated. icv, inferior cardinal 
vein; la, left atrium; lu, lung; lscv, left superior cardinal vein; pc, pericardial cavity; plc, pleural 
cavity; ppm, pleuropericardial membrane; pv, pulmonary vein; ra, right atrium; rscv, right 
superior cardinal vein; rsh, right sinus horn 
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Abstract 
 
Aims: The pericardium is a mesothelial double-walled sac that completely surrounds the adult 
heart including the root of the great vessels, and protects and anchors the heart inside the body 
cavity. The development of the pericardium has been histological described in humans, but has 
escaped any detailed descriptive or molecular analysis in mice. The aim of this study was to 
examine the normal development of the pleuropericardial membranes (PPMs), which give rise to 
the mature pericardium of the adult heart, during murine embryogenesis, and define the role of 
the T-box transcription factor 18 (Tbx18) therein. 
Methods and results: We describe murine pericardial development by histological analysis and 
examine gene expression during this process by in situ hybridization. Tbx18 is expressed in the 
PPMs and in a newly identified mesenchymal tissue thickening protruding into the 
pleuropericardial ducts (PPDs). In Tbx18-deficient embryos this mesenchymal tissue thickening 
does not form. The closure of the PPDs fails, allowing pleural and pericardial cavities to 
communicate, and the lung to touch the atria. We also show that the detachment of the PPMs 
from the lateral body wall is affected by the loss of Tbx18.  
Conclusion: Two distinct parallel processes are crucial for pericardial development. First, the 
PPMs are detached from the lateral body wall, and second, the PPDs are closed. These 
processes are coupled with the development and dorsocranial movement of the sinus venosus, 
and the positioning of the cardinal veins inside the pericardial cavity. During pericardial 
development Tbx18 is mainly required for the closure of the PPDs by the attachment of the 
PPMs to the hilus of the lung.  
 
Keywords: heart development, pericardium, sinus venosus, Tbx18 
 
Non-standard abbreviations and acronyms 
 
3D  three-dimensional 
Aldh1a2 aldehyde dehydrogenase family 1, subfamily A2 
E  embryonic day 
GFP  green fluorescent protein 
IFT  inflow tract 
Osr1  odd-skipped related 1 
PPD  pleuropericardial duct 
PPM  pleuropericardial membrane 
Tbx18  T-box 18 
Wt1  Wilms tumor 1 homolog
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Introduction 
 
The pericardium is a mesothelial sac that completely surrounds the heart and the root of the 
great vessels. It separates the pleural and pericardial cavities and anchors and protects the 
heart. It also secretes a serous fluid into the pericardial cavity that is necessary for the 
movement of the heart along this membraneous tissue.(1) Furthermore, Limana et al. 
demonstrated that the pericardial fluid and therefore an intact pericardium are required for 
reactivation of embryonic gene programs in a regenerating adult heart after myocardial 
infarction.(2) The complete or partial absence of the pericardium is a rare congenital disease in 
humans. In most cases the defect is positioned on the left side, and males are more affected 
than females.(3) In general these defects are asymptomatic. Nevertheless, partial defects of the 
pericardium may lead to the strangulation of the heart in the foramen and thereby to death. 
Additionally, the absence of the pericardium is often associated with other congenital cardiac 
anomalies and with diaphragmatic hernia.(4) The etiology and the underlying cellular and 
molecular mechanisms of these defects are still unclear necessitating a more thorough analysis 
of normal and abnormal pericardial development.  
In the human embryo, the pericardial cavity arises as a part of the intraembryonic cavity during 
gastrulation movements and the ventral closure of the embryo. First, the intraembryonic cavity is 
divided by the septum transversum, the precursor of the diaphragm, into a peritoneal and a 
thoracic cavity. This separation is initially incomplete leaving two pericardioperitoneal canals, 
which are positioned medially to the common cardinal veins, on each side of the foregut. The 
lung buds grow into these canals and expand dorsally, laterally and ventrally into the 
subcoelomic mesenchyme, leading to the degeneration of the laterodorsal mesenchyme and the 
formation of the pleural cavity. The disintegration of the surrounding mesenchyme is not 
complete, but two pleuropericardial folds persist between the growing lung and heart. These 
pleuropericardial folds contain the common cardinal veins and therefore are fixed to the posterior 
pole of the heart. The dorsocranial movements of the sinus venosus during the cardiac looping 
process shifts the common cardinal veins to a medial position, thereby stretching the 
pleuropericardial folds to become pleuropericardial membranes (PPMs).(5) In turn, the PPMs are 
released from the lateral body wall by several parallel processes including the degeneration of 
the subcoelomic mesenchyme, by the tensional force exerted by the growing rip cage, and the 
migration of the distal fixation points to a ventral position.(6) In the initial phase of these 
processes the pleuropericardial ducts (PPDs) between the lung and the heart are still needed for 
the movement of the lung, but will be closed during further development, possibly by fusion of 
the PPMs to the root of the lung. After this fusion event, pleural and pericardial cavities are 
completely separated. Further stretching and maturation of the PPMs form the parietal 
pericardium of human adults, which is attached posteriorly to the diaphragm, laterally to the 
mediastinal pleura, and ventrally to the sternum.(5,7,8)  
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The morphological, cellular and molecular processes regulating pericardial development in the 
mouse have been poorly defined. Only few relevant factors have been identified by the 
observation of pericardial defects in knockout mice. We recently published that the Wilms tumor 
1 gene (Wt1) and its interaction with retinoic acid signaling in the subcoelomic mesenchyme is 
necessary for pericardial development.(9) Moreover, the loss of odd-skipped related 1 (Osr1, also 
known as Odd1) leads to similar pericardial defects. Wt1 is downregulated in Osr1-deficient 
embryos, indicating that Osr1 may act upstream of Wt1 during pericardial development.(10)  
T-box 18 (Tbx18) is a member of the conserved family of T-box transcription factors that is 
expressed in the proepicardium, the epicardium, and the sinus horns at the venous pole of the 
murine heart.(11) The Tbx18-positive cells of the venous pole define a specialized precursor cell 
population, which is needed for the myocardialization of the sinus horns and the formation of the 
sinoatrial node.(12,13) Christoffels at al. also described the abnormal lateral position of the sinus 
horns inside the PPMs in Tbx18-deficient embryos. Here, we further analyze this defect, and 
present data that link sinus horn and pericardial development. We conclude that the release of 
the PPMs from the subcoelomic mesenchyme and the closure of the PPDs, the latter of which 
requires expression of Tbx18, are crucial processes in pericardial development. 
 
 
Material and Methods 
 
Mice and genotyping 
Transgenic mice harboring a knock-in of the GFP reporter in the Tbx18 locus allele (Tbx18tm2Akis, 
synonym: Tbx18GFP) were described before.(13) Heterozygous embryos (Tbx18GFP/+) were used 
as control embryos. All mice were maintained on an outbred (NMRI) background.  
For the generation of mutant embryos, heterozygous mice were intercrossed. Vaginal plugs 
were checked in the morning after mating, for timed pregnancies noon was taken as embryonic 
day (E) 0.5. Embryos were harvested in PBS, fixed in 4% paraformaldehyde overnight and 
stored in 100% methanol at –20oC before further use. Genomic DNA prepared from yolk sacs or 
tail biopsies was used for genotyping by PCR (protocols upon request). H. Hedrich, state head 
of the animal facility, approved the care of animals and experiments at Medizinische Hochschule 
Hannover. 
 
Histological analysis  
Embryos were fixed as mentioned above, paraffin embedded, and sectioned to 10 µm for 
histological stainings. Sections were stained with haematoxylin and eosin, following standard 
procedures. At least two embryos of each genotype were used for each analysis.  
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In situ hybridization analysis  
Nonradioactive in situ hybridization analysis with digoxigenin-labeled antisense riboprobes was 
performed as described.(14) At least two embryos of each genotype were used for each analysis. 
Details of used probes upon request. 
 
Proliferation assays and immunohistochemistry 
Cell proliferation in 12.5 embryos was investigated by detection of incorporated 5-bromo-2-
deoxyuridine (BrdU) on 5-µm sections of paraffin-embedded specimens similar to previously 
published protocols.(15) To define the Tbx18-positive region adjacent sections were stained for 
GFP by immunohistochemistry. For this GFP staining the primary antibody (rabbit polyclonal 
against GFP, 1:50, Santa Cruz Biotechnology) was detected using kits from Vector Laboratories 
(ABC Peroxidase Kit (Rabbit IgG), and DAB substrate kit). Tbx18-heterozygous littermates were 
used as controls. 
 
Documentation 
Sections were photographed using a Leica DM5000 microscope with Leica DFC300FX digital 
camera and afterwards processed in Adobe Photoshop CS3. 
 
Three-dimensional reconstruction 
For three-dimensional visualization and geometry reconstruction 10-µm serial sections of the 
whole heart of representative embryos of each genotype were used for haematoxylin and eosin 
stainings and documented as described. Further analysis was performed using the software 
“Amira” (Version 4.1.1, Mercury Computer Systems Inc) as described previously.(16) After 
documentation, the pictures were aligned, and regions for reconstruction were labeled. A three-
dimensional model was obtained after surface conversion.  
 
 
Results 
 
The murine PPMs are released from the posterior dorsolateral body wall starting from 
E12.5 
The closure of the PPDs and the detachment of the mesothelial PPMs from the lateral body wall 
occur in a complex series of morphogenetic processes. To visualize this program in mice, we 
prepared serial histological stainings of murine wildtype embryos starting from embryonic day 
(E) 9.5 to E14.5 (Figure 1, and data not shown) and generated schemes (Figure 2) of the 
thoracic cavity highlighting the key tissues.  
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Figure 1. Pericardial development in wildtype hearts. A – L, Histological analysis by 
haematoxylin and eosin stainings of PPM development was performed on transverse sections of 
a caudal, a mid-transverse, and a cranial section plane of wildtype hearts from E11.5 to E14.5. 
Asterisks highlight the subcoelomic lateral body wall mesenchyme. Arrowheads mark the 
attachment point of the PPMs to the lateral body wall. icv, inferior cardinal vein; la, left atrium; 
lcv, left cardinal vein; li, liver; lu, lung; lsh, left sinus horn; lv, left ventricle; pc, pericardial cavity; 
ppd, pleuropericardial duct; pl, pleural cavity; ppm, pleuropericardial membrane; ra, right atrium; 
rcv, right cardinal vein; rsh, right sinus horn; rv, right ventricle. 
 
The PPDs, which allowed the caudal movement of the lung at earlier developmental time points, 
were still open at E11.5. At this developmental stage, the inflow tract (IFT) of the heart including 
the right and left caval vein was positioned at a caudal position in the pericardial cavity (Figure 
1A, 1E and 1I, Figure 2A and 2D). During further development the IFT shifted cranially and was 
positioned on a mid-transverse section plane at E12.5 (compare Figure 1A and 1F). Additionally 
the size of the body cavity enlarged. Both processes stretched the PPMs, which were attached 
to the sinus horns, and thereby formed free PPMs that were visible at caudal levels of the heart, 
next to the IFT, but not at more cranial section planes starting from E12.5 (Figure 1B, 1F and 
1J). The PPMs were attached to the ventrolateral body wall distally, but were without contact to 
the dorsal mesocardium. Furthermore, the PPDs were not completely closed and a narrow duct 
was still detectable at E12.5 (Figure 1F, 2B, 2E, and 6C). Between E12.5 and E13.5, the lateral 
contact points of the PPMs moved ventrally following the distal extension of the ribs; 
mediodorsally the PPMs became attached to the hilus of the lung. Pleural and pericardial 
cavities were completely separated by the PPMs at E13.5 (Figure 1C, 1G, 2C, and 2F). 
Additionally, the subcoelomic mesenchyme in the pleural cavity and around the common 
cardinal veins became extremely loosely organized starting from E12.5, and was almost 
completely absent at E14.5. The PPMs were stretched into thin epithelial sheets during the 
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posteroanterior release from the dorsolateral mesenchyme and connected to the sternum by 
E14.5 (Figure 1D, 1H, 1L).  
 
Thus, the development of the PPMs can be divided into two processes, which act in parallel and 
might be coupled with the dorsocranial movement of the sinus venosus during heart looping and 
the growth of the whole embryo. First, the PPDs, which are necessary for the growth and 
descent of the emerging lung during early embryonic development, are closed until E13.5. 
Second, the PPMs are released from the lateral body wall, which starts around E12.5 in a 
posterior, dorsal domain of the pericardial cavity and progresses anteroventrally until E14.5. 
 
 
Figure 2. Schematic diagram of murine pericardial development. A – F, Scheme of 
pericardial development based on transverse and sagittal sections through the cardiac venous 
pole of wildtype embryos from E11.5 to E13.5. The lumen of the caval veins and the heart is 
marked in pale orange, the lung and trachea in blue, the PPDs in pink, a mesenchymal 
protrusion inside the PPDs in green (additionally marked by green arrows), and the degenerating 
subcoelomic mesenchyme in red. h, heart; lu, lung; pc, pericardial cavity; pl, pleural cavity; ppd, 
pleuropericardial duct; ppm, pleuropericardial membranes. 
 
Gene expression during pericardial development 
To define a molecular tool box and to get further insight into the mechanism regulating the 
development of the PPMs, we screened for genes that are expressed in the subcoelomic 
mesenchyme adjacent to the cardinal veins and/or in the developing PPMs by in situ 
hybridization (Figures 3 and 4). This search revealed new marker genes for the subcoelomic 
mesenchyme near the common cardinal veins at E12.5. They include Wilms tumor 1 (Wt1) and 
its target gene aldehyde dehydrogenase family 1, subfamily A2 (Aldh1a2, also known as 
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Raldh2) for which we previously reported a functional relevance in the subcoelomic 
mesenchyme for the release of the PPMs from the mediastinal pleura.(9) Furthermore, Meis 
homeobox 1 (Meis1) and Meis homeobox 2 (Meis2), target genes of retinoic acid signaling 
during forelimb development,(17) were detectable in the subcoelomic mesenchyme and confirmed 
the presence of active retinoic acid signaling in this domain (Figure 3A through 3D). We also 
detected expression of the transcription factor GATA binding protein 6 (Gata6) in the 
subcoelomic mesenchyme as well as in cardiomyocytes and the atrioventricular canal (Figure 
3E). Furthermore secreted frizzled-related protein 2 (Sfrp2), a modulator of Wnt signaling, the 
notch receptor Notch gene homolog 3 (Notch3), and sulfatase 1 (Sulf1) showed an expression in 
the laterodorsal mesenchyme and the dorsal mesocardium (Figure 3F through 3H). Eph receptor 
A3 (EphA3) and Eph receptor B2 (EphB2), two members of a large subfamily of Eph receptor 
tyrosine kinases, were specifically expressed in the subcoelomic mesenchyme, but not in other 
cardiac structures (Figure 3I and 3J). Furthermore, we detected the expression of receptor 
tyrosine kinase-like orphan receptor 1 (Ror1) and Osr1 in the laterodorsal mesenchyme (Figure 
3K and 3L). Some of these genes (Wt1, Aldh1a2, Gata6, and Sfrp2) were additionally expressed 
in a mesenchymal thickening inside the remaining PPDs, implicating them in the closure of these 
ducts.  
 
 
Figure 3. Gene expression in the subcoelomic mesenchyme. A – L, In situ hybridization 
analysis of genes encoding the mesothelial markers Wt1 and Aldh1a2 (A, B), the retinoic acid 
target gene Meis1 and Meis2 (C, D), the transcription factor Gata6 (E), the modulator of 
canonical Wnt signaling, Sfrp2 (F), the Notch receptor gene Notch3 (G), the sulfatase Sulf1 (H) 
and the kinases EphA3, EphB2, Ror1 and Osr1 (I – L) on transverse sections trough the venous 
pole region of wildtype hearts at E12.5. Asterisks highlight the subcoelomic lateral body wall 
mesenchyme. Arrowheads point to the remaining PPDs. lcv, left cardinal vein; pc, pericardial 
cavity; pl, pleural cavity; ppm, pleuropericardial membrane, rcv, right cardinal vein. 
 
2) Tbx18 in pericardial development 
 47 
Since the PPMs were almost completely released from the subcoelomic mesenchyme at E14.5, 
we screened at this stage for genes that are specifically expressed in this tissue and may be 
involved in the release from the body wall. By in situ hybridization analysis we detected 
expression of the mesothelial markers Wt1, Aldh1a2, Sulf1 and Upk3b in the PPMs of wildtype 
embryos (Figure 4A through 4D). Additionally, the sinus venosus marker Tbx18, a target gene of 
the canonical Wnt/beta-catenin signaling (Axin2) and Wnt signaling pathway components (Sfrp1, 
Sfrp2) were expressed in the PPMs at E14.5 (Figure 4E through 4H). Therefore, the 
subcoelomic mesenchyme and the mesenchymal thickening inside the PPDs are distinct 
molecular entities.  
 
Figure 4. Gene expression in the PPMs. A – H, In situ hybridization analysis on mid-
transverse sections of wildtype hearts for the mesothelial marker genes Wt1, Aldh1a2, Sulf1 and 
Upk3b, the sinus horn marker gene Tbx18, and components of the Wnt signaling pathway Axin2, 
Sfrp1 and Sfrp2 at E14.5. Probes are as indicated, arrowheads mark the attachment point of the 
PPMs to the lateral body wall. la, left atrium; lsh, left sinus horns; ppm, pleuropericardial 
membranes; ra, right atrium; rsh, right sinus horn. 
 
Tbx18 is required for PPD closure 
We recently demonstrated the importance of Tbx18 for the development of the venous pole of 
the heart including the positioning and myocardialization of the sinus horns, the myocardial parts 
of the right and left superior caval vein that are positioned within the pericardial cavity.(12) 
Additional to its expression in the developing sinus horns, we detected Tbx18 in the PPMs 
(Figure 4E) prompting us to investigate the role of Tbx18 in the development of this tissue. As 
Tbx18-null mice die shortly after birth due to severe malformations of the rib cage and 
respiratory insufficiency,(15) we were limited in our investigation of the pericardial phenotype to 
developmental stages up to E18.5 (Figure 5). 
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Figure 5. Developmental onset of pericardial defects in Tbx18-mutant embryos. A – D, G - 
L, Histological stainings with haematoxylin and eosin were performed on transverse sections 
through the venous pole of the heart. E,F, 3D-reconstruction of serial sections stained with 
haematoxylin and eosin to visualize the remaining lumen of the PPDs in control (E) and Tbx18-
mutant (F) embryos at E12.5. Genotypes and stages are as indicated. Arrowheads mark the 
attachment point of the PPMs to the lateral body wall; black arrows point to the remaining PPDs; 
green arrows point to the mesenchymal thickening that is necessary for the closure of the PPDs; 
red arrows point to the PPDs in Tbx18-mutant embryos at E12.5 that was visualized by 3D 
reconstruction, and white arrows highlight the volume of the cardinal veins. la, left atrium; lcv, left 
cardinal vein; li, liver; lu, lung; lsh, left sinus horn; lv, left ventricle; pc, pericardial cavity; ppd, 
pleuropericardial duct; pl, pleural cavity; ppm, pleuropericardial membrane; ra, right atrium; rcv, 
right cardinal vein; rsh, right sinus horn; rv, right ventricle. 
 
We started our analysis of Tbx18-deficient embryos by histological stainings. At E9.5 and E10.5, 
the positioning of the caval veins and the PPDs appeared unchanged in the Tbx18-mutant 
embryos (data not shown). At E11.5, the position of the caval veins was similar in both Tbx18-
heterozygous (these were phenotypically indistinguishable from Tbx18-wildtype embryos and 
therefore used as control embryos) and Tbx18-deficient embryos. However, a mesenchymal 
thickening protruded into the PPDs of control embryos, but was absent from the mutant PPDs 
(Figure 5A and 5B, marked by a green arrow in control embryos). At E12.5, PPMs were not yet 
detectable in mid-transverse sections in either genotypes, but the sinus horns were positioned 
slightly more laterally in Tbx18-mutant embryos. Furthermore, the mesenchymal protrusions 
were again visible in the PPDs of control embryos (Figure 2B and 2E, marked by a green arrow). 
Tbx18-deficient embryos lacked this mesenchymal thickening and the PPDs appeared broader 
(Figure 5C and 5D). In order to visualize the closure of the PPDs, we performed a 3-dimensional 
(3D) reconstruction of the remaining volume of the PPDs at E12.5. This reconstruction confirmed 
that the PPDs were nearly completely absent in control embryos, but not in Tbx18-mutant 
embryos at this stage (Figure 5C through 5F). In control embryos the PPMs were partly released 
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from the disappearing subcoelomic mesenchyme and fixed to a lateral position next to the 
emerging ribs at E13.5. In Tbx18-mutant embryos the loose subcoelomic mesenchyme was still 
present next to the sinus horns, and the PPDs were not closed allowing the lung to contact the 
atria (arrows in Figure 5H). As a consequence, the sinus horns were positioned much more 
laterally on both sides of Tbx18-deficient hearts (Figure 5G and 5H). In E14.5 control embryos, 
the PPMs presented as thin epithelial sheets, which completely surrounded the heart; they were 
fixed dorsally to the hilus of the lung and ventrally to the sternum. The right and left sinus horns 
were positioned medial directly next to the hilus of the lung. In contrast, the PPMs of Tbx18-
deficient embryos did not completely surround the heart, they were fixed at a lateral position and 
not to the sternum. Additionally the PPDs were still open, leaving a space for the lung to touch 
the atria. The right and left sinus horns were positioned abnormal laterally and within the PPMs 
at this stage (Figure 5I and 5J) and at E18.5 (Figure 5K and 5L). 
 
To allow higher resolution imaging of PPD closure, we additionally performed histological 
analysis of E10.5 to E14.5 wildtype and mutant embryos on sagittal sections (Figure 6). No 
differences between control and mutant PPDs were detectable at E10.5 (Figure 6A and 6F). 
Starting from E11.5, the width of the PPDs decreased, mainly by the ingrowth of a dorsal 
mesenchymal tissue block located between the sinus horns and the atria (marked by a green 
arrow in Figure 2D, 2E, 6B and 6C), leaving only a small canal in control embryos at E12.5. In 
Tbx18-deficient embryos, this mesenchymal tissue protrusion was not established and the width 
of the PPDs failed to decrease (Figure 6G and 6H). In control embryos of E13.5 and E14.5, the 
PPDs were completely closed and the pleural and pericardial cavities fully separated (Figure 6D 
and 6E). In Tbx18-deficient embryos the PPDs remained open and the lung touched the atria at 
E13.5 and E14.5 (Figure 6I and 6J). Therefore, failure of formation of the mesenchymal tissue 
protrusion may underlie the observed defects in PPM and sinus horn development in Tbx18-
deficient embryos. 
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Figure 6. Insufficient closure of the PPD in Tbx18-mutant embryos. A – J, Histological 
analysis by haematoxylin and eosin staining was performed on sagittal sections of E10.5 to 
E14.5 control and Tbx18-deficient hearts as indicated. Arrows highlight the remaining PPDs in 
Tbx18-deficient embryos. Green arrowheads mark the mesenchymal thickening in control 
embryos and its loss, respectively, in Tbx18-deficient embryos. lu, lung; oft, outflow tract; pc, 
pericardial cavity; pl, pleural cavity; ppm, pleuropericardial membrane; ra, right atrium; rsh, right 
sinus horn; rv, right ventricle; sh, sinus horn. 
 
Tbx18 is expressed and required in the developing sinus horns and an adjacent medial, 
highly proliferative mesenchymal tissue protrusion 
The mesenchymal tissue protrusion that is positioned at the border between the sinus horns and 
the atria adjacent to the PPDs in the control embryos was not established in Tbx18-deficient 
embryos. Gene expression analysis in control embryos revealed that this mesenchymal 
protrusion was strongly positive for expression of Tbx18 and GFP at E12.5 (Figure 7C and 7H). 
Obviously, lack of this tissue in the mutant situation did not permit to check for maintenance of 
expression of Tbx18 and GFP, respectively. However, other expression domains of Tbx18 
including the sinus horns and the epicardium were reflected by the expression of GFP in Tbx18-
heterozygous and Tbx18-deficient embryos at all analyzed stages (Figure 7A through 7O). This 
strongly indicates that Tbx18 is cell-autonomously required for the formation of the 
mesenchymal tissue protrusion, which itself is necessary for PPD closure, but not for the 
precursor population of the sinus horns and the epicardium.  
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Figure 7. The PPDs in Tbx18-deficient embryos remains open due to the loss of a 
mesenchymal, Tbx18-positive thickening. A – O, In situ hybridization analysis on sagittal 
sections of wildtype hearts from E10.5 to E14.5. The expression of GFP reflects Tbx18 
expression in control embryos (A – J). In Tbx18-deficient embryos the mesenchymal structure 
inside the right PPD is missing (K – L). Stages are as indicated on top, the genotype on the left 
side and the used RNA probe is indicated on the right side. Arrows point to the open right PPD. 
Green arrowheads mark the GFP-positive mesenchymal protrusion in control embryos and its 
loss, respectively, in Tbx18-deficient embryos at E12.5. icv, inferior caval vein; lu, lung; ppm, 
pleuropericardial membrane; ra, right atrium; rscv; right superior caval vein; rsh, right sinus horn; 
rv, right ventricle. 
 
To define the molecular nature of the mesenchymal tissue protrusion that is likely to mediate 
PPD closure, we screened by in situ hybridization analysis for genes that are expressed in this 
thickening. First, we verified the expression of Tbx18 on transverse sections of heterozygous 
embryos (Figure 8A). Mannan-binding lectin serine peptidase 1 (Masp1), the GATA binding 
proteins Gata4 and Gata6, and sulfatase 1 (Sulf1) were expressed in this mesenchymal 
aggregate in control embryos at E12.5 (Figure 8C, 8E, 8G, and 8I). Due to the lack of this 
structure in the PPDs of Tbx18-mutant embryos, expression of these genes was undetectable in 
mutant embryos. However, other expression domains of these genes were unchanged in control 
and Tbx18-deficient embryos. Masp1 was expressed in parts of the left atrium, weakly in the 
mesothelial sheet of the pleural and pericardial cavities, and next to the trachea in both wildtype 
and Tbx18-deficient embryos (Figure 8C and 8D). Gata4 and Gata6 showed expression in the 
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myocardium of the atria and ventricles, Gata6 was additionally expressed in the laterodorsal 
mesenchyme next to the sinus horns of both genotypes (Figure 8E through 8H). As the 
expression of the mesothelial marker genes Sulf1, Aldh1a2, Wt1 and Upk3b were not altered in 
the mesothelial lining covering the pleural and pericardial cavities, the epicardium and/or the 
subcoelomic mesenchyme next to the sinus horns, these domains seemed unaffected in Tbx18-
deficient embryos (Figure 8I through 8P). 
 
 
Figure 8. Analysis of cellular molecular changes in the lateral body wall and the PPDs of 
Tbx18-deficient mice. A – P, In situ hybridization analysis of marker expression carried out on 
transverse sections through the venous pole region of control and Tbx18-mutant mouse hearts 
at E12.5. Genotypes and probes are as indicated. Green arrowheads point to the Tbx18-positive 
mesenchymal protrusion that is important for the closure of the PPDs in control embryos. Black 
arrows highlight the mesothelial lining of the PPDs. Note the enlarged width of the PPDs in 
Tbx18-deficient embryos. lcv, left cardinal vein; lu, lung; ra, right atrium; rcv, right cardinal vein 
 
We conclude that Tbx18 is required for establishment of a mesenchymal tissue thickening that 
protrudes into the PPDs to eventually seal them off. In contrast, Tbx18 seems dispensable in the 
subcoelomic mesenchyme and the PPMs.  
 
To achieve further insides into the mechanism of the closure of the PPDs we analyzed 
proliferation by BrdU incorporation assay in both control and Tbx18-mutant embryos at E12.5 
2) Tbx18 in pericardial development 
 53 
(Figure 9). GFP protein was detectable in the mesenchyme of the right sinus horn, the 
mesothelial lining of the PPDs, the PPMs and in the epicardium in either genotypes. This 
analysis depicted a high number of proliferating cells in the GFP-positive mesenchymal 
protrusion in control embryos at E12.5, the stage in which the closure of the PPDs occurred 
(marked by a green arrowhead in Figure 9A and 9C). This GFP-positive mesenchymal 
thickening, and therefore the proliferating cell, was absent in Tbx18-mutant embryos (Figure 9B 
and 9D). In summary, the high proliferation rate in the mesenchymal protrusion inside the PPDs 
in wildtype embryos suggests that an increase in cell number of this mesenchymal thickening 
leads to a constriction of the PPDs, resulting in a complete separation of the pleural and 
pericardial cavities. 
 
 
 
Figure 9. Cellular changes in the PPDs of Tbx18-deficient mice. A, B, Immunohistochemical 
analysis for GFP protein in control (genotype: Tbx18GFP/+) and Tbx18-deficient embryos on 
sagittal sections through the PPDs at E12.5. C, D, Analysis of proliferation by BrdU 
immunohistochemistry in the boxed domain of the PPDs performed on sagittal sections through 
the PPDs at E12.5. BrdU positive cells are labeled in brown in C and D. Green arrowheads point 
to the mesenchymal protrusion inside the PPDs of control embryos. epi, epicardium; lu, lung; 
ppm, pleuropericardial membrane; ra, right atrium; rsh, right sinus horn. 
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Discussion 
 
Partial absence of the pericardium is a rare congenital defect, which may lead to a strangulation 
of the heart and subsequent death.(18) The etiologies of this defect have remained unclear. Our 
analysis of murine pericardial development in wildtype and Tbx18-mutant embryos together with 
our recent analysis of Wt1-deficient(9) mice point to complex morphogenetic processes which are 
coupled with the development of the sinus horns at the cardiac venous pole.  
 
Etiology of pericardial defects 
During pericardial development two processes occur that are linked to the dorsocranial 
movement of the sinus venosus during heart looping and the growth of the whole embryo. On 
the one hand, the PPMs are detached from the underlying subcoelomic body wall mesenchyme. 
On the other hand, the PPDs, two canals in the septum transversum on both sides of the 
midline, are closed by the ingrowth of a mesenchymal thickening inside the PPDs. These 
processes act in parallel and, most likely, are independent from each other. Deficiencies in either 
of these two processes may cause pericardial hernia.  
The subcoelomic mesenchyme next to the caval veins first becomes loosely organized and 
disappears completely between E12.5 and E14.5, a process that is coupled with the release of 
the PPMs. Molecular changes in the laterodorsal mesenchyme lead to severe pericardial 
phenotypes that are characterized by persisting subcoelomic mesenchyme and PPMs tethered 
to the lateral body wall. We recently showed that Wt1 and its target gene Aldh1a2 are required 
for the detachment of the PPMs from the laterodorsal mesenchyme. Retinoic acid induced 
apoptosis is absent in the Wt1-deficient embryos and therefore the subcoelomic mesenchyme 
persists. The PPMs are not released form the lateral body wall, the caval veins become 
abnormally positioned laterally, and the PPDs are not closed in Wt1-mutant embryos. However, 
the newly described Tbx18-positive mesenchymal thickening inside the PPDs, that is necessary 
for the closure of the PPDs, develops normally in the Wt1-deficient embryos. During further 
development, the growth of the pericardial cavity increases the tension of the laterally tethered 
caval veins resulting in PPM disruption and hernia in Wt1-deficient mice. (9) In our wildtype 
analysis we detected expression of Meis1 and Meis2, which are direct target genes of retinoic 
acid signaling during limb development,(17) in the subcoelomic mesenchyme. This finding 
additionally points to a role of retinoic acid signaling during pericardial development. A similar 
pericardial defect including the persistence of the PPDs is described in Osr1-deficient embryos. 
Furthermore, the expression of Wt1 is downregulated in the subcoelomic mesenchyme next to 
the caval vein in these Osr1-mutant embryos, pointing to a direct regulation of Wt1 by Osr1 
during detachment of the PPMs.(10) Nevertheless, further analysis is required to fully understand 
the molecular mechanism regulating the detachment of the PPMs from the subcoelomic 
mesenchyme. The degeneration of the subcoelomic mesenchyme next to the sinus horns may 
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be similar to the enlargement of the middle ear cavities. Also the mesenchymal cells next to the 
developing tympanic cavity first become loosely packed and afterwards disappear through both 
apoptosis and redistribution of cells over the increasing surface area.(19) However, the molecular 
mechanisms regulating this process are also not understood by now.(20) 
The second process of pericardial development is the closure of the PPDs. These ducts are 
necessary for the growth and descent of the emerging lung during early embryonic development, 
and they have to be closed for the complete separation of the pleural and pericardial cavities. A 
closed pericardium is essential to retain the low pressure in the pleural cavity during 
breathing,(21) and also for the formation of the pericardial fluid that may have a supportive role in 
regenerating heart cells after myocardial infarction.(2) Our analysis of Tbx18-deficient mouse 
embryos revealed the importance of Tbx18 for the closure of the PPDs during murine embryonic 
development. In Tbx18-deficient embryos an undescribed pericardial defect was obvious, which 
was characterized by persisting PPDs and an incomplete detachment of the PPMs from the 
mediastinal pleura. 
 
A Tbx18-positive medial mesenchymal protrusion inside the PPDs is necessary for its the 
closure  
The Tbx18-positive mesenchymal protrusions, which are positioned at the lateral wall of the 
PPMs, had a key role during the closure of the PPDs. In wildtype embryos, this mesenchymal 
thickening first constricted the width of the PPDs, and later completely separated pleural and 
pericardial cavities by fusion to the hilus of the lung around E13.0. In both control and Tbx18-
deficient mouse embryos a Wt1+ and Upk3b+ mesothelial layer was lining the complete PPDs, 
which was gone specifically at the attachment point after closure of the PPDs in control 
embryos. A similar process was proposed for the development of the human pericardium; 
therefore the fusion of two mesothelial surfaces might be the reason for the closure of the PPDs 
in humans(7) and, as our analysis revealed, also in mice. In humans, the ingrowth of the PPMs 
into the PPDs is sometimes described as an active movement of pleuropericardial folds that 
thereby get stretched and become thin PPMs.(4,22) We could not confirm this active ingrowth of 
pleuropericardial folds during murine pericardial development, as we were not able to detect the 
described pericardial folds in different mouse embryos and section planes from E9.5 to E18.5. 
Complete serial sections of murine embryos starting from E9.5 demonstrated that the 
interpretation of an active ingrowth of the PPMs might be the result of focusing to improper 
section planes instead of serial sections, maybe caused by the limited human material available.  
After the PPMs were connected to the hilus of the lung, highly dynamic and complex 
morphogenetic changes occur. The whole embryo, and as a result the size of the thoracic cavity 
grew rapidly. In parallel the subcoelomic mesenchyme degenerated completely between E13.0 
and E14.5, coupled with a dramatic increase in the size of the pleural cavity and the lung. During 
these growth processes the PPMs were fixed at the lateral body wall, the venous pole of the 
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heart and the hilus of the lung, therefore the PPMs were stretched out to thin epithelial layers. 
Maybe the tensile force onto the PPMs is, at least partially, necessary for the detachment from 
the lateral body wall, a mechanism that was already proposed for the development of the human 
pericardium.(6) In Tbx18-deficient embryos the attachment of the PPMs to the hilus of the lung 
and therefore the closure of the PPDs failed. As a consequence the PPMs were only fixed to the 
venous pole of the heart, but not to the lung hilus, and the caval veins were torn laterally due to 
the tension onto the PPMs during further embryonic development. To some extent the 
incomplete detachment from the lateral body wall in Tbx18-mutant embryos might be a 
secondary effect of the missing medial fixation of the caval veins to the lung hilus, and not a 
primary effect caused by cellular changes in the laterodorsal mesenchyme, since marker genes 
for the subcoelomic mesenchyme were not affected by the loss of Tbx18.  
However, further analysis in mice is required to define the molecular mechanism regulating 
pericardial development. During our current analysis we were able to identify new marker genes 
for the subcoelomic mesenchyme and the PPMs in wildtype embryos. None of these genes 
(Meis1, Meis2, Gata6, Sfrp1, Sfrp2, Axin2, Notch3, Sulf1, EphA3, EphB2, Ror1, Masp1) was 
published to be involved in the development of the PPMs before. Therefore, our future work will 
focus on the role of these genes during pericardial development to obtain a molecular network 
for the underlying processes. 
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Abstract 
 
Aims: The pericardium is a mesothelial sac that entirely surrounds the heart and the roots of the 
great vessels; its complete or partial absence is a rare congenital human disease. Little is known 
about the molecular mechanism regulating its embryonic development both in mice and humans. 
Here, we wish to define a role of canonical (beta-catenin (Ctnnb1))-dependent Wnt signaling in 
murine pericardial development.  
Methods and results: We analyzed the role of canonical Wnt signaling during early and late 
steps of pericardial development by histological stainings and in situ hybridization analysis of 
different pericardium specific Ctnnb1 loss- and gain-of-function mutant embryos. Both genetic 
manipulations resulted in distinct pericardial malformations. Additionally, we examined defects in 
the formation of the sinus horns at the cardiac venous pole that are coupled with pericardial 
defects in Ctnnb1-deficient mice. 
Conclusion: Canonical Wnt signaling regulates the detachment of the pleuropericardial 
membranes from the subcoelomic mesenchyme of the lateral body wall. Both, pericardial and 
venous pole development are coupled. However, myocardialization of the sinus horns is 
independent from their positioning inside the pericardial cavity.  
 
Keywords: beta-catenin, pericardium, sinus venosus, heart development 
 
 
Non-standard abbreviations and acronyms 
 
Ctnnb1 beta-catenin 
E  embryonic day 
PPD  pleuropericardial duct 
PPM  pleuropericardial membrane 
SAN  sinoatrial node 
Tbx  T-box 
Wt1  Wilms tumor 1 homolog 
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Introduction 
 
The adult pericardium is a thin mesothelial tissue that completely surrounds the heart and the 
roots of the great blood vessels. It is attached dorsally to the hilus of the lung, ventrally to the 
sternum, and caudally to the diaphragm. Its functions are the separation of the pleural and 
pericardial cavities and thereby the protection and fixation of the heart inside the thoracic 
cavity.(1) The complete or partial absence of the pericardium is a rare congenital human defect 
that is asymptomatic in most of the patients. However, the foramen formed by the partial 
absence of the pericardium may lead to heart strangulation, and therefore may cause death.(2) 
The molecular mechanism regulating pericardial development are only partially deciphered, and 
further analysis is required to understand the genetic background of congenital pericardial 
defects.  
The mature pericardium derives from the embryonic pleuropericardial membranes (PPMs), 
which initially arise as two mesothelial tissue layers. At embryonic day (E) 9.5 and E10.5, the 
complete body wall of the thoracic cavity, a thin mesothelial tissue layer, is referred to as 
(embryonic) pericardium. This body wall thickens during the onset of development and the 
mesothelial lining of the pericardial cavity will give rise to the detached PPMs starting from 
E12.5. During the development of the PPMs two complex morphogenetic processes occur in 
parallel. First, the mesothelial lining of the pericardial cavity, which will form the PPMs, detaches 
from the subcoelomic mesenchyme of the lateral body wall. Recently, we demonstrated the 
importance of the transcription factor Wilms tumor 1 (Wt1), which is expressed in the 
subcoelomic mesenchyme, for the degeneration of this tissue. In Wt1-deficient embryos the 
caval veins remain tethered to the persisting subcoelomic mesenchyme and were not 
myocardialized. In wildtype embryos Wt1 induces the expression of the aldehyde 
dehydrogenase family 1, subfamily A2 (Aldh1a2, also known as Raldh2), and the resulting 
retinoic acid signaling leads to apoptosis of the subcoelomic mesenchyme that is crucial for the 
release of the PPMs(3). In a second morphogenetic process the pleuropericardial ducts (PPDs), 
which are essential for the movements of the lung during early embryonic development, are 
closed by an attachment of the PPMs to the hilus of the lung. This process requires expression 
of the T-box transcription factor Tbx18 (Norden et al., manuscript in preparation).  
Wnt signaling pathways are important for the regulation of gene transcription as well as cell 
proliferation, cell fate decisions, and cell polarity during embryonic development in both 
vertebrates and non-vertebrates.(4) Wnt proteins are secreted factors that act by binding to 
Frizzled (Fzd) receptors, thereby stabilizing the protein beta-catenin (Ctnnb1). Ctnnb1 is the 
central component of the canonical Wnt signaling pathway, and transmits Wnt signals to the 
TCF/LEF complex in the nucleus, thereby inducing transcription of target genes such as Axin2.(5) 
At E9.5 and E10.5, the canonical Wnt signaling ligand wingless-related MMTV integration site 2 
(Wnt2, also known as m-irp) is expressed in the embryonic pericardium, which is also the 
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thoracic body wall at this stage of development.(6) Additional, the BAT-gal reporter mouse line 
confirmed active Ctnnb1-signaling in the embryonic pericardium at E9.5.(7) 
However, until now the role of canonical Wnt/β-catenin signaling in murine pericardial 
development has remained elusive. Here, we examine different conditional Ctnnb1 loss- and 
gain-of-function mutant mice. We show that both pericardium-specific loss as well as ectopic 
activation of canonical Wnt signaling result in pericardial defects, which are associated with 
deficiencies in the sinus venosus region of the heart. Additionally, we show that 
myocardialization of the sinus horns, the intrapericardial parts of the caval veins, is independent 
from the position inside the pericardial cavity.  
 
 
Material and Methods 
 
Mice and genotyping 
Mice with a knock in of the cre-recombinase into the Tbx18 locus (Tbx18tm4(cre)Akis, synonym: 
Tbx18cre)(8) and mice that express the cre-recombinase under the control of a Prrx1 derived 
enhancer (Tg(Prrx1-cre)1Cjt, synonym: Prrx1-cre)(9) were described before. Additionally, we 
used two published reporter lines, the lacZ expressing reporter line Gt(ROSA)26Sor (synonym: 
R26LacZ)(10) and a fluorescent reporter line (Gt(ROSA)26Sortm4(ACTB-tdTomato,-EGFP)Luo/J, synonym: 
R26mTmG)(11). For the conditional inactivation of Ctnnb1 we used mice with two loxP sites flanking 
the Ctnnb1 locus from exon 2 to exon 6 (Ctnnb1tm2Kem, synonym: Ctnnb1fx)(12), the ectopic 
activation of beta-catenin was achieved by using mice with two loxP sites flanking exon 3 of the 
Ctnnb1 locus (Ctnnb1tm1Mmt, synonym: Ctnnb1(Ex3)fl).(13)  
All mice were maintained on an outbred (NMRI) background. The Tbx18cre specific Ctnnb1 loss-
of-function mutants (Tbx18cre/+;Ctnnb1fx/fx) were obtained from matings of Tbx18cre/+;Ctnnb1fx/+ 
males with Ctnnb1fx/fx (Ctnnb1tm2Kem)(12) females. Tbx18cre specific Ctnnb1 gain-of-function mice 
(Tbx18cre/+;Ctnnb1(Ex3)fl/+) were derived from matings of Tbx18cre/+ males with Ctnnb1(Ex3)fl/(Ex3)fl 
(Ctnnb1tm1Mmt)(13) females. Prrx1-cre specific loss-of-function mutants (Prrx1-cre;Ctnnb1fx/fx) 
derived from matings of heterozygous Prrx1cre/+ (Tg(Prrx1-cre)1Cjt)(9) males with Ctnnb1fx/fx 
(Ctnnb1tm2Kem)(12) females. The Prrx1-cre specific gain-of function mutants were obtained by 
intercrossing of Prrx1-cre/+ (Tg(Prrx1-cre)1Cjt)(9) males with Ctnnb1(Ex3)fl/(Ex3)fl (Ctnnb1tm1Mmt)(13) 
females. For the analysis of the conditional Ctnnb1 loss-of-function phenotype, heterozygous 
animals (Tbx18cre/+;Ctnnb1fx/+ or Prrx1-cre/+; Ctnnb1fx/+) were used as control embryos. For the 
Ctnnb1 gain-of-function analysis Ctnnb1(Ex3)fl/+ heterozygous embryos without a cre-allele were 
used as control. 
Mouse embryos were generated by timed matings; observation of vaginal plug was designated 
as embryonic day (E) 0.5. Embryos were harvested in PBS, fixed in 4% paraformaldehyde 
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overnight, and stored in 100% methanol at –20oC before further use. Genomic DNA prepared 
from yolk sacs or tail biopsies was used for genotyping by PCR (protocols upon request). H. 
Hedrich, state head of the animal facility, approved the care of animals and experiments at 
Medizinische Hochschule Hannover. 
 
Histological analysis  
Embryos were fixed as described above, paraffin embedded, and sectioned to 10-µm for 
histological stainings. Sections were stained with haematoxylin and eosin, following standard 
procedures. At least two embryos of each genotype were used for each analysis.  
 
In situ hybridization analysis  
Nonradioactive in situ hybridization analysis with digoxigenin-labeled antisense riboprobes was 
performed as described.(14) At least two embryos of each genotype were used for each analysis. 
Details of used probes upon request. 
 
Immunohistochemistry 
For immunofluorescence analysis, mouse monoclonal antibody against GFP (1:250, 
11814460001, Roche), and rabbit polyclonal antibody against Wt1 (1:400, C-19, Santa Cruz 
Biotechnology) were used as primary antibodies. Alexa488 donkey-anti-mouse (1:250, 
Invitrogen) and biotinylated goat-anti-rabbit (1:250, 111-065-003, Dianova) were used as 
secondary antibodies. Nuclei were stained with 4',6-diamidino-2-phenylindol (DAPI) (Roth). 
Paraffin embedded embryos were sectioned to 5-µm, and all used sections were pressure 
cooked for 3 min in antigen unmasking solution (H-3300, Vector Laboratories Inc). Endogenous 
peroxidase activity was blocked by 3% H2O2. The signal was amplified using either the Tyramide 
Signal Amplification (TSA) system from Perkin-Elmer (NEL702001KT, Perkin Elmer LAS) or the 
Mouse-on-mouse (M.O.M.) immunodetection kit from Vector Laboratories (PK-2200, Vector 
Labs). The anti-GFP staining was performed in a second experiment directly after the first 
immunodetection was finished and followed the published protocols. 
 
Documentation 
Sections were photographed using a Leica DM5000 microscope with Leica DFC300FX digital 
camera and afterwards processed in Adobe Photoshop CS3.  
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Results 
 
Canonical Wnt signaling in the PPMs and the body wall mesenchyme is necessary for the 
release of the PPMs from the mediastinal pleura  
Mice that express the cre-recombinase under the control of a paired related homeobox 1 (Prrx1, 
also known as Prx1) derived enhancer (Tg(Prrx1-cre)1Cjt, synonym: Prrx1-cre)(9) mediate 
recombination of loxP-flanked sequences in the early limb bud and craniofacial mesenchyme,(15) 
as well as in precursor cells of the outflow tract and right ventricle.(16) We detected an additional 
contribution of Prrx1-cre derived cells to the PPMs using R26LacZ reporter analysis(10) (Figure 1).  
 
 
Figure 1. Prrx1-cre derived cells contribute to the PPMs. A – H, Lineage tracing experiments 
by in situ hybridization for Cre and LacZ on neighboring transverse sections trough the venous 
pole in Prrx1-cre;R26LacZ/+ embryos from E9.5 to E13.5. I thorough I’’, Immunofluorescence 
analysis of GFP (green) and Wt1 (red) on transverse section of a Prrx1-cre;R26mTmG/+embryo at 
E14.5. G and G’ as well as H and H’ show the right and left PPM, respectively, of the same 
embryo. I’ and I’’ are magnifications of the embryo seen in I. Stages and probes are as 
indicated. Arrows mark the Cre expression domains, arrowheads LacZ-positive regions in Prrx1-
cre;R26LacZ/+ embryos. ep, embryonic pericardium; la, left atrium; lcv, left cardinal vein; lscv, left 
superior caval vein; lv, left ventricle; ppm, pleuropericardial membrane; ra, right atrium; rcv, right 
cardinal vein; rv, right ventricle. 
 
In Prrx1-cre;R26LacZ/+ embryos Cre and LacZ expression were detectable in the lateral body wall 
mesenchyme next to the caval veins, the embryonic pericardium of the body wall, and the right 
ventricle at E9.5 and E10.5 (Figure 1A through 1D). The cre expression in the subcoelomic 
mesenchyme next to the caval veins was downregulated after E12.5, but these cells remained 
positive for LacZ at E12.5 and E13.5 (Figure 1E through 1H’). At E13.5, cre expression was 
absent from the free parts of the PPMs, but LacZ gene expression was detectable in the PPMs 
and in the body wall next to the attachment points of the PPMs at this stage (Figure 1G, 1G’, 1H 
and 1H’). Because of the bright and distinct GFP expression after cre-recombination in the 
R26mTmG mice(11) we additionally performed lineage analysis using this reporter mouse line. The 
GFP protein was coexpressed with the mesothelial marker Wt1 in the PPMs at E14.5 (Figure 1I 
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through 1I’’), which confirmed the derivation of the PPMs from Prrx1-cre-positive precursor cells, 
and the suitability of this mouse line for pericardium-specific gene manipulation. 
 
Prrx1-cre and Axin2, a target gene of the canonical Wnt signaling pathway,(17) are coexpressed 
in the embryonic pericardium of wildtype embryos at E9.5 and E10.5 (Figure 1A, 1C, 5B, and 5I) 
suggesting that this pathway is active in pericardial precursor cells. To investigate the relevance 
of canonical Wnt signaling for pericardial development, we crossed Prrx1-cre males with females 
harboring a floxed allele of Ctnnb1 (Ctnnb1fx)(12) to specifically delete Ctnnb1 expression during 
early pericardial development starting from E9.5 (Figure 2) 
 
 
Figure 2. Developmental onset of pericardial defects in Prrx1-cre;Ctnnb1fx/fx mutant 
embryos. A through H, Histological analysis by haematoxylin and eosin stainings of transverse 
section of control (left column) and Prrx1-cre;Ctnnb1fx/fx mutant (right column) hearts from 
E18.5 to E12.5. Stages are as indicated. Asterisks mark the subcoelomic mesenchyme. Arrows 
point to the canal between lung and atrium in the mutant embryos, arrowheads indicate the 
attachment point of the PPMs to the lateral body wall. la, left atrium; lcv, left cardinal vein; lscv, 
left superior caval vein; lu, lung; lv, left ventricle; ppm, pleuropericardial membrane; ra, right 
atrium; rcv, right cardinal vein; rscv, right superior caval vein; rv, right ventricle; SAN, sinoatrial 
node. 
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As previously described, Prrx1-cre;Ctnnb1fx/fx mutant embryos survived embryonic development 
and died shortly after birth.(18) In E18.5 control embryos (genotype: Prrx1-cre;Ctnnb1fx/+) pleural 
and pericardial cavities were separated by the PPMs that were attached dorsally to the hilus of 
the lung and ventrally to the sternum. In Prrx1-cre;Ctnnb1fx/fx mutant embryos, the PPMs were 
not connected to the hilus of the lung, leaving a space for a lobe of the lung to lie inside the 
pericardial cavity; the sinus horns were abnormally positioned laterally. The release of the PPMs 
from the lateral body wall was disturbed, resulting in the formation of short PPMs and indicating 
that Ctnnb1 is indeed required for pericardial development. Additionally, the whole heart was 
tilted to the left within the pericardial cavity and the ribs were not fused ventrally (Figure 2A and 
2B).  
To define the developmental onset of this phenotype, we analyzed mutant embryos at earlier 
embryonic stages. At E14.5, the PPMs were almost completely released from the lateral body 
wall in control embryos. In Prrx1-cre;Ctnnb1fx/fx mutant embryos the sinus horns occupied an 
abnormal lateral position within the very short PPMs that were also tethered by a persisting 
subcoelomic mesenchyme to the body wall. Thus, a wide canal on the right side allowed the 
lung to touch the atria at this stage (Figure 2C and 2D). At E13.5, the PPMs were partly released 
from the lateral body wall and only a small portion of the subcoelomic mesenchyme in the 
pleural cavity was detectable in control embryos. In contrast, the caval veins were tethered 
entirely to the persisting subcoelomic mesenchyme, PPMs were not apparent, and the heart was 
tilted to the left (Figure 2E and 2F). Furthermore, the whole body wall consisted of loose 
mesenchymal cells, and ribs were not developed. At E12.5, the PPMs were not detached from 
the lateral body wall and the venous pole region of the heart was similar developed in both 
control and Ctnnb1-mutant embryos (Figure 2G and 2H). We conclude from this histological 
analysis of Prrx1-cre;Ctnnb1fx/fx mutant embryos that canonical Wnt/Ctnnb1 signaling is required 
for the release of the PPMs from the subcoelomic mesenchyme.  
 
Myocardialization of the sinus horns is unaffected in Prrx1-cre;Ctnnb1fx/fx mutant mice 
To further clarify the observed defects in Prrx1-cre;Ctnnb1fx/fx mutant mice we additionally 
examined these mutant mice for molecular marker expression by in situ hybridization (Figure 3). 
We recently reported on the pericardial defects in Wt1-deficient embryos,(3) that were highly 
similar to the ones observed here: the caval veins remained tethered in the subcoelomic 
mesenchyme, only short PPMs developed and a canal remained between the lung and the atria. 
Additionally, the sinus horns were not myocardialized in the Wt1-mutant embryos, which we 
attributed to their abnormal lateral position inside the PPMs.(3) In contrast and despite their 
abnormal lateral position, sinus horns were myocardialized in E18.5 Prrx1-cre;Ctnnb1fx/fx mutant 
mice as revealed by normal expression of the cardiomyocyte specific troponin I cardiac 3, 
(Tnni3, also known as cTnI) (Figure 3A, 3A’, 3C and 3C’). The transcription factor T-box 18 
(Tbx18) is important for myocardialization of the sinus horns(19) and pericardial development 
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(Norden et al., manuscript in preparation). Tbx18 was expressed in the sinus horn myocardium, 
the SAN, and weakly in the PPMs of both genotypes at E18.5 (Figure 3B, 3B’, 3D, and 3D’). The 
SAN marker gene hyperpolarization-activated, cyclic nucleotide-gated K+ 4 (Hcn4) and the 
mesothelial marker gene Uroplakin 3b (Upk3b)(20) were unchanged in Prrx1-cre;Ctnnb1fx/fx 
embryos at E18.5 (Figure 3E trough 3H’). Therefore, pericardium specific loss of Ctnnb1 does 
not affect SAN formation, mesothelial identity of the PPMs, and sinus horn myocardialization.  
 
 
Figure 3. Myocardialization of the sinus horns is independent from its position next to the 
midline. A through H’, In situ hybridization analysis of cardiomyocyte specific Tnni3 (A and its 
magnification A’,C and C’), the sinus horn marker gene Tbx18 (B and B’, D and D’) , the 
sinoatrial node marker gene Hcn4 (E and E’, G and G’), and the mesothelial marker gene Upk3b 
(F and F’, H and H’) in transverse sections of whole hearts and detailed analysis of the sinus 
venosus in control and Prrx1-cre;Ctnnb1fx/fx mutant embryos at E18.5. Black boxes in A and C 
mark the magnified sections in A’ or C’, respectively. Genotypes are as indicated. Arrows 
indicate the connection between right atrium and lung in Prrx1-cre,Ctnnb1fx/fx mutant embryos. 
la, left atrium; lsh, left sinus horn; ppm, pleuropericardial membrane; ra, right atrium; rsh, right 
sinus horn; SAN, sinoatrial node. 
 
At E14.5, the sinus horns as well as the SAN were positive for the cardiomyocyte specific gene 
Tnni3 and the sinus horn marker Tbx18 in control and in Prrx1-cre;Ctnnb1fx/fx embryos, excluding 
a delay of myocardialization in these mutant embryos (Figure 4A through 4D’). This analysis 
additionally revealed that the pericardial phenotype observed in Prrx1-cre;Ctnnb1fx/fx  embryos is 
not secondary to a loss of Wt1. In control embryos Wt1 was expressed in all mesothelial tissues 
including the PPMs at E14.5, and in the subcoelomic mesenchyme until its disintegration around 
this stage (Figure 4E and 4E’). In embryos with Prrx1-cre specific deletion of canonical 
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Wnt/Ctnnb1 signaling, the subcoelomic mesenchyme persisted and expressed Wt1 at E14.5. 
The mesothelial character of the short PPMs was maintained in the Ctnnb1-deficient embryos 
(Figure 4G, and 4G’). The Prrx1-cre specific deletion of Ctnnb1 was confirmed by the absence of 
Axin2 expression in Prrx1-cre;Ctnnb1fx/fx mutant PPMs, in control embryos weak Axin2 
expression was detectable in the PPMs at E14,5 (Figure 4F, 4F’, 4H, and 4H’). In conclusion, 
the Prrx1-cre specific loss of Ctnnb1 affected early pericardial development. The subcoelomic 
mesenchyme was almost completely maintained, and the caval veins remained tethered inside 
this mesenchyme and positioned laterally next to the body wall. 
 
 
Figure 4. Myocardialization of the sinus horns is not affected in Prrx1-cre;Ctnnb1fx/fx 
mutant embryos. A through H’, In situ hybridization analysis of cardiomyocyte specific Tnni3 
(A and its magnification A’; C and C’), the sinus horn marker gene Tbx18 (B and B’, D and D’), 
the mesothelial and subcoelomic mesenchyme marker gene Wt1 (E and E’, G and G’), and the 
Ctnnb1 target gene Axin2 (F and F’, H and H’) on transverse sections of the heart at E14.5. 
Genotypes are as indicated. Black boxes in A and C mark the magnified sections in A’ or C’, 
respectively. Arrows indicate the canal between right atrium and lung in Prrx1-cre,Ctnnb1fx/fx 
mutant embryos, arrowheads highlight the PPMs. la, left atrium; lsh, left sinus horn; lu, lung; pc, 
pericardial cavity; pl, pleural cavity; ppm, pleuropericardial membrane; ra, right atrium; rsh, right 
sinus horn; SAN, sinoatrial node. 
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Tbx18cre-specific inactivation of canonical Wnt/Ctnnb1 signaling leads to pericardial 
defects 
The T-box transcription factor Tbx18 is expressed the proepicardium at E9.5, the epicardium 
until E16.5, and the myocardium of the left ventricle and the interventricular septum starting from 
E10.5. Additionally, Tbx18 expression is found in the developing mesothelial lining of the 
pericardial cavity and the PPDs, which will give rise to the PPMs, starting from E10.5 (Figure 
5).(21) At E9.5, we did not detect expression of Tbx18 in the embryonic pericardium, whereas the 
pro-/epicardium already expressed Tbx18. Tbx18 expression did not overlap with the weak 
expression of Axin2 in the embryonic pericardium at this stage (Figure 5A and 5B). We verified 
the contribution of Tbx18-positive cells to the PPMs by lineage tracing experiments. In 
Tbx18cre/+;R26mTmG/+ embryos(11) the entire PPMs were positive for GFP that overlapped with the 
mesothelial marker Wt1(22) at E18.5 (Figure 5C and 5D). Additionally, the sinus horns, the 
epicardium, and part of the left ventricle were derived from Tbx18-positive progenitor cells. 
Therefore, the Tbx18cre/+ mouse line provides an additional and independent tool to analyze 
Ctnnb1 function during pericardial development. 
 
 
Figure 5. The PPMs are derived from Tbx18-positive precursor cells. A, B, In situ 
hybridization analysis on mid-transverse sections for expression of Tbx18 and Axin2 in wildtype 
embryos at E9.5. C, D, Immunofluorescence analysis of GFP, which marks Tbx18-derived cells, 
and the mesothelial marker Wt1 in Tbx18cre/+;R26mTmG/+ embryos at E18.5. E through L’, In situ 
hybridization analysis for Tbx18 and the canonical Wnt target gene Axin2 in control and 
Tbx18cre/+;Ctnnb1fx/fx mutant embryos at E10.5 and E12.5. Genotypes and probes are as 
indicated. At E12.5, two pictures of each genotype and probe show the right and left PPM of one 
embryo seperately. Arrows point to the Tbx18-positive domain of the sinus horns, arrowheads 
mark the embryonic pericardium at E10.5 or the separated PPMs at E12.5. AVC, atrioventricular 
canal; ep, embryonic pericardium; epi, epicardium, la, left atrium; lcv, left cardinal vein; lsh, left 
sinus horn; lu, lung; lv, left ventricle; ppm, pleuropericardial membrane; ra, right atrium; rcv, right 
cardinal vein; rsh, right sinus horn; rv, right ventricle; vv, venous valves.  
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Heterozygous embryos (genotype: Tbx18cre/+;Ctnnb1fx/+) were undistinguishable from wildtype 
embryos and used as controls. Tbx18 was expressed in the epicardium, the sinus horns and 
weakly in the mesothelial lining of the lung and the pleural cavity of both control and conditional 
Ctnnb1 loss-of-function embryos (genotype: Tbx18cre/+;Ctnnb1fx/fx) at E10.5 and E12.5. 
Additionally, Tbx18 was detected in the right and left PPM, mainly next to the hilus of the lung, in 
both genotypes at E12.5, excluding a regulation of the cre-driver Tbx18 by the loss of Ctnnb1 
(Figure 5E through 5H’). In situ hybridization analysis for the Ctnnb1 target gene Axin2 verified 
the loss of canonical Wnt/Ctnnb1 signaling in the sinus horns at E10.5 and E12.5 as well as the 
PPMs at E12.5. Thus, the Tbx18cre-mediated loss of Ctnnb1 occurred specifically in the 
separated PPMs starting from E12.5, as Tbx18 and Axin2 were not coexpressed in the 
pericardium in earlier embryonic stages. In Tbx18-negative regions, e.g. the atrioventricular 
canal and the venous valves, Axin2 expression was maintained in Tbx18cre/+;Ctnnb1fx/fx embryos 
(Figure 5I through 5L’).  
 
The Tbx18cre/+;Ctnnb1fx/fx embryos died shortly after birth due to skeletal malformations. Thus, 
we started our analysis of pericardial phenotypes by histological analysis at E18.5 (Figure 6). In 
control embryos, the PPMs were attached dorsally to the hilus of the lung and ventrally to the 
sternum and thereby completely surrounded the heart including the right and left sinus horns at 
this stage and at E14.5 (Figure 6A, 6C, 6E and 6G). In Tbx18cre specific Ctnnb1 knockout 
embryos, the release of the PPMs from the lateral body wall was disturbed. In mid-transverse 
section planes the PPMs were connected dorsally to the hilus of the lung, but the ventral 
attachment points were shifted laterally to a more dorsal position (Figure 6A through 6H). 
However, in more cranial section planes the caval veins were positioned laterally inside the 
PPMs at E14.5 and E18.5. Moreover, a thin mesothelial tissue bridge was fixing the right sinus 
horn to the hilus of the lung at E18.5 (marked by an arrow in Figure 6D, 7J and 7L). At E12.5, 
the PPMs were still attached to the lateral body wall in both genotypes and completely 
embedded in the subcoelomic mesenchyme at a more cranial level (Figure 6I through 6L). The 
subcoelomic mesenchyme, which was positioned next to the caval veins at E12.5, was 
completely vanished in both genotypes at E14.5 and E18.5. Additionally to the pericardial 
defects the dorsal domain of the sinus horns was thinner and the lung showed a bend at the 
position of the sinus horns in Tbx18cre specific Ctnnb1-deficient embryos at E18.5 (Figure 6D). In 
conclusion, the conditional loss of Ctnnb1 by Tbx18cre recombination leads to an incomplete 
detachment of the lateral PPMs from the mediastinal pleura. At the medial attachment point a 
thin mesothelial tissue bridge fixed the sinus horn to the hilus of the lung at cranial levels and 
tethers the sinus horns in an abnormal lateral position within the PPMs. 
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Figure 6. Developmental onset of pericardial defects in Tbx18cre/+;Ctnnb1fx/fx mutant 
embryos. A through L, Histological analysis by haematoxylin and eosin staining of PPM 
development was performed on mid-transverse (left columns) and cranial (right columns) 
sections of E18.5 to E12.5 control and Tbx18cre specific Ctnnb1-mutantჼ hearts as indicated. 
C,D, Inserted clippings clarify the attachment of the PPM to the hilus of the lung on cranial 
transverse sections. The arrow highlights the thin mesothelial tissue bridge connecting the right 
sinus horn to the hilus of the lung. Arrowheads mark the attachment point of the PPMs to the 
body wall. la, left atrium; lcv, left cardinal vein; lsh, left sinus horn; lu, lung; lv, left ventricle; ppm, 
pleuropericardial membrane; ra, right atrium; rcv, right cardinal vein; rsh, right sinus horn; rv, 
right ventricle. 
 
The mesothelial character of the PPMs is maintained in Tbx18cre/+;Ctnnb1fx/fx  embryos 
The swelling and subsequent disintegration of the subcoelomic mesenchyme is required for the 
release of the PPMs from the lateral body wall.(3) In Tbx18cre/+;Ctnnb1fx/fx embryos Wt1 
expression was maintained in the subcoelomic mesenchyme at E12.5 (Figure 7D), and this 
mesenchyme was completely vanished at E18.5 (Figure 6B). The mesothelial marker genes Wt1 
and Upk3b were detectable in the lining of the pericardial and pleural cavities, the epicardium 
and the lining of the lung in both control and mutant embryos at E12.5 and E18.5 (Figure 7A, 7B, 
7D, 7E, 7G, 7H, 7J, and 7K). Therefore, the mesothelial character of the PPMs was preserved in 
Tbx18cre/+;Ctnnb1fx/fx embryos. Tbx18 is detectable in the mesothelial lining of the pleural and 
pericardial cavities, the epicardium and the sinus horns of both genotypes at E12.5 (Figure 7C 
and 7F). This expression of Tbx18 in the mesothelial tissues was downregulated in control and 
Tbx18cre/+;Ctnnb1fx/fx embryos at E18.5 (Figure 7I and 7L), excluding a regulation of Tbx18 
expression by canonical Wnt signaling. The expression of Tbx18 in the dorsal domain of the 
sinus horns was reduced in Tbx18cre/+;Ctnnb1fx/fx mutant embryos (Figure 7L). (Norden et al., 
manuscript in preparation). 
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Figure 7. The mesothelial character of the PPMS is maintained. A through L, Expression of 
mesothelial marker genes Wt1 and Upk3b, and the sinus horn marker Tbx18 in control and 
Tbx18cre/+;Ctnnb1fx/fx embryos analyzed by in situ hybridization at E12.5 (A trough F) and E18.5 
(G through L). Genotypes and probes are as indicated. Asterisks highlight the subcoelomic 
mesenchyme next to the caval veins at E12.5, arrows mark the thin mesothelial tissue bridge 
connecting the right sinus horn to the hilus of the lung in mutant embryos, and arrowheads point 
to the PPM. la, left atrium; lcv, left cardinal vein; lu, lung; ppm, pleuropericardial membrane; ra, 
right atrium; rcv, right cardinal vein; rsh, right sinus horn. 
 
Ectopic activation of canonical Wnt/beta-catenin signaling induces undifferentiated cell 
aggregates  
To understand the role of Ctnnb1-dependent Wnt signaling during pericardial development in 
more detail, we used a gain-of-function approach with conditional (Tbx18cre- or Prrx1cre-
mediated) expression of a stabilized form of Ctnnb1 (Ctnnb1(Ex3)fl).(13)  
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Figure 8. Ectopic activation of canonical Wnt signaling during pericardial development. A 
through D, Histological staining of control and Tbx18cre;Ctnnb1(Ex3)fl/+ mutant mice at E12.5 (A 
and B) or Prrx1-cre;Ctnnb1(Ex3)fl/+ embryos at E18.5 (C and D). E through R, In situ 
hybridization analysis on transverse sections of control and Prrx1-cre;Ctnnb1(Ex3)fl/+ mutant mice 
at E18.5 (E through J) or E14.5 (K through R). Genotypes and probes are as indicated. Black 
boxes in E and H mark the magnified sections in E’ or H’, respectively. Arrows point to the 
connection between lung and atria, arrowheads mark ectopic cell aggregates. la, left atrium; lcv, 
left cardinal vein; lsh, left sinus horn; lu, lung; lv, left ventricle; pc, pericardial cavity; pl, pleural 
cavity; ppm, pleuropericardial membrane; ra, right atrium; rcv, right cardinal vein;  rsh, right sinus 
horn; SAN, sinoatrial node. 
 
Tbx18cre/+;Ctnnb1(Ex3)fl/+ embryos died during midgestation before the release of the PPMs from 
the subcoelomic mesenchyme had started. Histological analysis of surviving embryos uncovered 
a highly enlarged pericardial cavity, the myocardium of the heart was thinned, the heart was 
tilted inside the pericardial cavity, and ectopic cell aggregates were detectable next to the sinus 
horns at E12.5 (Figure 8A and 8B). The effects of Tbx18cre-mediated activation of Ctnnb1 for 
sinus horn and epicardial development will be described elsewhere (Norden et al., manuscript in 
preparation). Due to the early embryonic lethality, we abandoned the analysis of pericardial 
development in these mice. 
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Prrx1-cre;Ctnnb1(Ex3)fl/+ gain-of-function embryos survived embryonic development and died 
shortly after birth.(18) By histological staining with haematoxylin and eosin we detected a 
pericardial phenotype that was reminiscent to the observed alterations in Prrx1-cre;Ctnnb1fx/fx 
loss-of-function embryos. The PPMs were not completely released from the lateral body wall and 
a wide canal allowed the lung to encircle the right atrium in Prrx1-cre;Ctnnb1(Ex3)fl/+ gain-of-
function embryos at E18.5 (Figure 8C and 8D). In situ hybridization analysis for cardiomyocyte 
specific Tnni3 demonstrated that mutant sinus horns were myocardialized at E18.5 and E14.5; 
confirming that myocardialization of the sinus horns occurs independently from the normal 
location next to the hilus of the lung (Figure 8E’, 8H’, 8K, and 8O). In the Prrx1-cre;Ctnnb1(Ex3)fl/+ 
embryos we detected Tnni3-negative cells, which were positive for a target gene of canonical 
Ctnnb1-mediated Wnt signaling, Axin2, at E18.5 (Figure 8F and 8I). Ectopic Axin2-positive cell 
aggregates were also detectable next to the PPMs at E14.5 (Figure 8L and 8P). The 
mesothelial, Wt1-positive character was preserved in the PPMs at both stages (Figure 8G, 8J, 
8M, and 8Q). Furthermore, the persisting subcoelomic mesenchyme in Prrx1-cre;Ctnnb1(Ex3)fl/+ 
gain-of-function embryos expressed Wt1. In control embryos this mesenchyme was completely 
resolved at E18.5 and E14.5, but expressed Wt1 at earlier developmental stages (Figure 7A). 
The remaining subcoelomic mesenchyme and the PPMs in Prrx1-cre;Ctnnb1(Ex3)fl/+ embryos 
additionally showed expression of the Wnt antagonist secreted frizzled-related protein 2 (Sfrp2), 
which was also detectable in the PPMs and the attachment point of the PPMs to the sternum in 
control embryos at E14.5 (Figure 8N and 8R) and in the subcoelomic mesenchyme next to the 
caval veins at E12.5 (data not shown). 
 
 
Discussion 
 
Myocardialization of the sinus horns is independent from a medial positioning 
We have recently reported that Wt1-deficient mice feature laterally positioned, non-
myocardialized sinus horns. We speculated at this time that the lack of sinus horn 
myocardialization was due to the physical separation from sources of differentiation signals.(3) 
However, in Prrx1-cre;Ctnnb1 loss- and gain-of-function mutants the sinus horns were 
myocardialized despite their lateralization and tethering to the persisting subcoelomic 
mesenchyme. This excludes a function of canonical Wnt/Ctnnb1 signaling in the subcoelomic 
mesenchyme or the PPMs for the myocardialization of the sinus horns, and also excludes a role 
of the dorsal mesocardium/lung hilus tissue as a source of the respective signals. Nevertheless, 
our study shows the necessity of Ctnnb1-mediated Wnt signaling in the lateral body wall 
mesenchyme and/or the PPMs for the development of the pericardium, especially the release of 
the PPMs from the subcoelomic mesenchyme. Additionally, in the developing sinus horns 
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canonical Wnt/Ctnnb1 signaling is required for the proliferation of precursor cells and, as a 
result, for the myocardialization of the Tbx18-positive dorsal domain of the sinus horns (Norden 
et al., manuscript submitted).  
 
Ctnnb1-mediated Wnt signaling is necessary for murine pericardial development 
Our analysis revealed the requirement of canonical Wnt signaling for diverse steps during 
murine pericardial development. The conditional Ctnnb1 loss- and gain-of-function approaches 
using two different cre-lines (Tbx18cre and Prrx1-cre) caused pericardial deficiencies. We were 
able to distinguish between early (Prrx1-cre) and late (Tbx18cre) effects of deletion and ectopic 
activation of Ctnnb1, respectively. 
Prrx1-cre and Axin2 (which marks active canonical Wnt signaling) were coexpressed in the 
embryonic pericardium at E9.5 and E10.5; coexpression was maintained in the lateral body wall 
next to the detachment point of the PPMs until at least E12.5. Thus, early canonical Wnt/Ctnnb1 
signaling in the embryonic pericardium and/or the lateral body wall next to the detachment point 
of the PPMs is crucial for the release of the PPMs from the subcoelomic mesenchyme. During 
heart development, canonical Wnt signaling keeps progenitor cells of the second heart field in a 
proliferative, undifferentiated state, therefore these cells are able to elongate the growing 
heart.(1) Currently, the progenitor cells of the PPMs and the precise molecular role of Ctnnb1 
during its development remain unidentified. However, the levels of active Ctnnb1 signaling in this 
domain have to be tightly regulated, as both the loss and the ectopic activation of Ctnnb1 
resulted in severe pericardial defects.  
We recently published that the release of the PPMs from the lateral body wall is a prerequisite 
for the correct repositioning of the cardinal veins medially to the hilus of the lung,(3) therefore the 
communication between the lung and the atria is most likely a secondary defect. The failure to 
release the PPMs from the lateral body wall may also cause the tilting of the heart within the 
pericardial cavity. In wildtype mouse embryos, the release of the PPMs from the subcoelomic 
mesenchyme and the stretching of the PPMs are coupled with the development and 
dorsocranial movement of the sinus venosus of the heart (Norden et al., manuscript in 
preparation). The fixation of the caval veins to the persisting subcoelomic mesenchyme may 
therefore hamper the dorsocranial movements of the sinus venosus and the positioning of the 
heart inside the pericardial cavity. Further analysis of the PPM release will focus on the 
examination of new Ctnnb1 target genes in the subcoelomic mesenchyme during pericardial 
development and molecular changes, e.g. proliferation and apoptosis, in this domain. The 
underlying mechanisms of the disappearance of the subcoelomic mesenchyme may be similar 
to the development of middle ear cavities. However, the molecular mechanisms regulating these 
processes have remained elusive until now.(23) In the middle ear apoptosis of the mesenchyme 
may act in parallel with a redistribution of the mesenchymal cells over the increasing area of the 
growing middle ear capsule.(24,25)   
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Our Tbx18cre specific deletion of Ctnnb1 addressed a later requirement for canonical Wnt 
signaling for pericardial development since Tbx18 (and therefore cre) and Axin2 are not 
coexpressed in the lateral body wall at E9.5 and E10.5. Tbx18cre primarily affected Ctnnb1 
expression during PPM release starting from E12.5. Pericardial defects in Tbx18cre;Ctnnb1fx/fx 
mutant embryos, therefore, argues that Wnt signaling is required for the progression of the 
detachment of the Tbx18-derived PPMs from the lateral body wall as well. Notably, canonical 
Wnt signaling is not required for the medial anchoring of the PPMs to the lung hilus as no canal 
between the lung and atria was detectable in the Tbx18cre;Ctnnb1fx/fx mutant embryos. However, 
the caval veins were positioned laterally inside the PPMs in these embryos, especially at E18.5 
when a thin mesothelial tissue bridge connected the right sinus horn to the hilus of the lung in 
Tbx18cre;Ctnnb1fx/fx mutant embryos. The molecular and cellular mechanisms underlying these 
defects remain to be defined. Tension stress onto the PPMs during the growth of the embryo 
and the thoracic cavity might be a mechanical factor influencing the release of the PPMs from 
the lateral body wall, as proposed for the development of the human pericardium.(26)  
In conclusion, this study uncovers the importance of the Wnt/Ctnnb1 signaling pathway for 
pericardial development The levels of active Wnt/Ctnnb1 signaling have to be tightly regulated 
during these processes, as both the loss and the ectopic activation of Ctnnb1 resulted in 
pericardial abnormalities. 
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Abstract 
 
Rationale: Canonical (beta-catenin (Ctnnb1))-dependent Wnt signaling plays an important role 
in the development of second heart field (SHF) derived structures of the heart by regulating 
precursor cell proliferation. The signaling pathways that regulate the most posterior elongation of 
the heart i.e. the addition of the systemic venous return from a Tbx18-positive precursor 
population, have remained elusive. 
Objective: To define the role of Ctnnb1-dependent Wnt signaling in the development of the 
cardiac venous pole. 
Methods and Results: We show by in situ hybridization analysis that Wnt pathway components 
are expressed and canonical Wnt signaling is active in the developing sinus horns. We analyzed 
sinus horn (Tbx18cre) specific Ctnnb1 loss- and gain-of-function mutant embryos. In Ctnnb1-
deficient embryos, the dorsal part of the sinus horns is not myocardialized, but consists of 
myofibroblasts; the sinoatrial node (SAN) is unaffected. Stabilization of Ctnnb1 in this domain 
results in the formation of undifferentiated cell aggregates. Analysis of cellular changes revealed 
a role of canonical Wnt signaling in proliferation of the Tbx18+ mesenchymal progenitor cell 
population.  
Conclusions: Canonical Wnt signaling in the Tbx18+Nkx2-5- mesenchymal cell population of the 
sinus horns is important for the balance between proliferation and differentiation of these 
precursors.  
 
Keywords: Canonical Wnt signaling, beta-catenin, sinus horn, cardiac progenitor 
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Non-standard abbreviations and acronyms 
 
3D  three-dimensional 
AVC  atrio-ventricular canal 
Bmp  bone morphogenetic protein 
Ctnnb1 beta-catenin 
DAPI  4',6-diamidino-2-phenylindol 
E  embryonic day 
Fgf   fibroblast growth factor 
FHF  first heart field 
Fzd  frizzled homolog  
Gja  gap junction protein, alpha 
GFP  green fluorescent protein 
Nkx2-5 NK2 transcription factor related, locus 5 
OFT  outflow tract 
SAN  sinoatrial node 
Sfrp  secreted frizzled-related protein 
Shh  sonic hedgehog 
SHF  second heart field 
Tbx  T-box 
Tnni  troponin I, cardiac 
Wnt  wingless-related MMTV integration site 
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What is known? 
• Canonical (beta-catenin (Ctnnb1))-dependent signaling is important for the balance between 
proliferation and terminal differentiation in the precursor cell population of the second heart 
field, which contributes to the formation of atria, right ventricle, and outflow tract.  
• The sinus horns, the myocardialized parts of the intrapericardial aspects of the common 
cardinal veins, are added to the posterior pole of the already formed heart tube from a 
distinct mesenchymal Tbx18+ cell population from E9.5 to E14.5. 
• The sinoatrial node (SAN), the main pacemaker of the heart, also derives from a Tbx18+ 
precursor cell population at the posterior pole of the heart. 
 
 
What new information does this article contribute? 
• Canonical Wnt signaling is active during sinus horn development. 
• Ctnnb1 is required for myocardialization of the dorsal part of the sinus horns. 
• Ctnnb1 is not required for SAN formation. 
• Canonical Wnt signaling positively regulates proliferation of the Tbx18+Nkx2-5- precursor cell 
population of the sinus horns, but prevents differentiation into cardiomyocytes when 
constitutively activated.  
 
 
Novelty and significance 
The cardiac venous pole consists of the sinus horns, the sinus venarum, the coronary sinus 
(persisting left superior caval vein in the mouse), and the sinoatrial node (SAN). Although it is a 
common focus of congenital malformations and arrhythmias, the signals and factors that 
regulate its formation are largely unknown. Here, we identify canonical Wnt signaling as a crucial 
pathway in the formation of fully myocardialized sinus horns. We show that canonical Wnt 
signaling is required and sufficient to maintain the proliferation of Tbx18+ mesenchymal 
precursor cells of the sinus horns. However, Ctnnb1-dependent Wnt signaling is dispensable for 
the development of the SAN, which also derives from Tbx18+ progenitors. 
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Introduction 
 
The multi-chambered mammalian heart develops by a complex morphogenetic process from a 
linear tube, which is established shortly after gastrulation as a functional organ. Growth and 
elongation of this simple tube only partly relies on proliferation of cardiomyocytes within the tube 
itself but largely depend on recruitment and differentiation of mesenchymal precursor cells at the 
poles. In fact, myocardium of the linear heart tube, which is established at E8.25 in the mouse, 
will only contribute to the left ventricle. Myocardium of the outflow tract (OFT), right ventricle, and 
large portions of the atria of the mature heart derive from a population of splanchnic mesodermal 
precursor cells that is contiguous and dorsal to the heart tube. These pharyngeal mesodermal 
precursors, which are now termed the second heart field (SHF), express ISL1 transcription 
factor, LIM/homeodomain (Isl1), T-box 1 (Tbx1) and the fibroblast growth factor genes Fgf8 and 
Fgf10, and therefore, are molecularly distinguished from the progenitors of the linear heart tube, 
the first heart field (FHF), which express NK2 transcription factor related, locus 5 (Nkx2-5), T-box 
5 (Tbx5) and heart and neural crest derivatives expressed transcript 1 (Hand1).1 Although 
molecularly distinct, both precursor populations can be envisaged as a continuum that allows the 
spatiotemporally regulated contribution of precursors to the growing heart tube.  
The systemic venous return consists of the myocardial sleeves of the right superior and inferior 
caval veins, the sinus venarum, the coronary sinus (persisting left superior caval vein in the 
mouse), and the sinoatrial node (SAN).2 This posterior part of the heart develops after the 
chambers have been established at E9.5, by recruitment and myocardialization of mesenchymal 
precursor cells to the common atrium until E14.5.3,4 This precursor cell pool is distinguished from 
the FHF and SHF by presence of T-box 18 (Tbx18) and absence of Nkx2-5 expression. Loss of 
Tbx18 in this "third heart field" leads to a delay in myocardialization of the sinus horns, and a 
marked reduction of the SAN. 
Continuous elongation of the heart tube requires a tight control of proliferation and deployment 
of mesenchymal progenitor cells. A number of studies identified canonical Wnt signaling as a 
crucial upstream regulator of SHF proliferation. Conditional inactivation of beta-catenin (Ctnnb1) 
under control of the myocyte enhancer factor 2C (Mef2c) in the anterior aspect of the SHF 
resulted in reduced proliferation and subsequent truncation of the OFT and right ventricle.5 More 
recently, Tian et al. showed that wingless-related MMTV integration site 2 (Wnt2) acts in the 
posterior portion of the SHF to stimulate proliferation of precursor cells and subsequent 
formation of a portion of the atrioventricular canal (AVC) and the atria.6 Thus, canonical Wnt 
signaling maintains proliferation in the SHF to allow the polar elongation of the heart. Notably, 
Wnt signaling does not play such a role in the FHF. In fact, Ctnnb1 inhibits cardiac differentiation 
in this region.  
The signaling pathways that regulate the most posterior elongation of the heart i.e. the addition 
of the systemic venous return, have remained elusive. Although the SHF and sinus horn 
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mesoderm bear different molecular signatures (Nkx2-5+Isl+ vs Nkx2-5-Tbx18+) we wondered 
whether canonical Wnt signaling exerts a similar function in the latter context. Here, we present 
data obtained from genetic loss- and gain-of function experiments in the mouse that 
demonstrate a function of canonical/Ctnnb1-dependent Wnt signaling in sinus horn 
development.  
 
 
Material and Methods 
Mice  
Mice with a knock-in of the cre recombinase gene into the Tbx18 locus (Tbx18tm4(cre)Akis, 
synonym: Tbx18cre),7 mice with two loxP sites flanking the Ctnnb1 locus from exon 2 to exon 6 
(Ctnnb1tm2Kem, synonym: Ctnnb1fx),8 mice with two loxP sites flanking exon 3 of the Ctnnb1 locus 
(Ctnnb1tm1Mmt, synonym: Ctnnb1(Ex3)fl),9 and the fluorescent reporter line (Gt(ROSA)26Sortm4(ACTB-
tdTomato,-EGFP)Luo/J, synonym: R26mTmG)10 were all described before. All lines were maintained on an 
outbred (NMRI) background. Animal care was in accordance with national and institutional 
guidelines. 
 
An expanded Materials and Methods section is available in the online data supplement. 
 
 
Results 
(Canonical) Wnt signaling in sinus horn development 
To determine the spatiotemporal involvement of Wnt signaling in sinus horn development, the 
expression of genes encoding Wnt ligands (Wnt1, -2, -2b, -3, -3a, -4, -5a, -5b, -6, -7a, -7b, -8a, -
8b, -9a, -9b, -10a, -10b, -11, and Wnt16), Frizzled receptors (Fzd1 to Fzd10), and Wnt 
antagonists of the family of Secreted frizzled-related proteins (Sfrp1 to Sfrp5), was analyzed by 
in situ hybridization on sections of the cardiac venous pole. Since sinus horn development 
occurs from embryonic day (E) 9.5 to E14.5, we used E10.5, E12.5, and E14.5 embryos for this 
expression screen (Figure 1, Online Figure 1). Most of the tested components of the Wnt 
signaling pathway showed no caval vein specific gene expression. However, the Wnt ligand 
Wnt2 was expressed in the walls of the left and right cardinal vein that bulged into the pericardial 
cavity at E10.5 (Online Figure 1A), E12.5 and E14.5 (Figure 1A and 1E). Expression of Wnt10a 
was detectable in both caval veins and in the atrial and ventricular myocardium at E14.5 (Figure 
1B and 1F). Fzd7 and Sfrp1 were expressed in the intrapericardial component of the cardinal 
veins at all tested embryonic stages (Online Figure 1C and 1D; Figure 1C and 1D, 1G and 1H). 
Sfrp1 was additionally expressed in the left ventricle at E12.5, and in both the atria and the left 
ventricle at E14.5. Therefore, genes encoding two Wnt ligands (Wnt2, Wnt10a), one Frizzled 
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receptor (Fzd7) as well as one Wnt antagonist (Sfrp1) were expressed in the developing sinus 
horns, pointing to a role of Wnt signaling in the development of this posterior portion of the 
murine heart. To verify that the presence of these ligands and receptors is associated with 
activation of the canonical Wnt signaling pathway, we investigated expression of Axin2, a bona 
fide target of Ctnnb1-dependent Wnt signaling. Weak Axin2 expression was detectable in the 
sinus horns of wildtype embryos at all three stages. Furthermore, Axin2 was found in the venous 
valves, the atrial septum, and the developing AVC at E12.5 and E14.5 (Figure 1I and 1M). 
 
Defects of the systemic venous return from sinus horn specific inactivation of Ctnnb1 
To investigate the role of canonical Wnt signaling in sinus horn development, we employed a 
tissue-specific inactivation approach using a Tbx18cre line generated in our laboratory7 and a 
floxed allele of Ctnnb1 (Ctnnb1fx),8 the unique intracellular mediator of this signaling pathway. 
The T-box transcription factor gene Tbx18 has multiple sites of expression in the developing 
heart including the proepicardial organ at E9.5, the epicardium until E16.5, and the myocardium 
of the left ventricle and the interventricular septum. Importantly, Tbx18 expression marks the 
sinus horn lineage from E8.25 onwards,11 allowing the specific genetic removal of Ctnnb1 in 
mesenchymal precursors as well as in differentiated myocardium of this cardiac subregion. The 
specific inactivation of the canonical Wnt signaling pathway in the Tbx18cre-expressing sinus 
horns was confirmed by absence of Axin2 expression in the sinus horns but its maintenance at 
other sites of cardiac expression at E12.5 and E14.5 (Figure 1J and 1N). Expression of Tbx18 
was unaffected, excluding that the cre driver activity depends on Ctnnb1 function (Figure 1K and 
1L, 1O and 1P). 
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Figure 1. Wnt signaling in sinus horn development. In situ hybridization analysis on 
transverse sections through the venous pole region for expression of Wnt pathway components 
in wildtype embryos (A through H), and of Axin2 and Tbx18 (I through P) in control (genotype: 
Tbx18cre/+;Ctnnb1fx/+) and Tbx18cre/+;Ctnnb1fx/fx mutant sinus horns. Arrowheads point to the 
intrapericardial components of the left and right cardinal vein. Stages and probes are as 
indicated. AVC, atrioventricular canal; lcv, left cardinal vein; lscv, left superior caval veins; ra, 
right atrium; rcv, right cardinal vein; rscv, right superior caval vein; vv, venous valves.  
 
Tbx18cre/+;Ctnnb1fx/fx mice survived embryogenesis but skeletal malformations led to respiratory 
failure shortly after birth. At E18.5, the mutant heart appeared normal on a gross morphological 
level (data not shown). Histological analysis revealed that chambers, valves, and septa were 
unaffected; sinus horns were positioned next to the midline and within the pericardial cavity as in 
control embryos (Figure 2A and 2B). However, in situ hybridization analysis for cardiomyocyte 
specific troponin I cardiac 3, (Tnni3, also known as cTnI) revealed a specific lack of myocardium 
in the dorsal part of the sinus horns next to the pleuropericardial membrane in mutant hearts 
(Figure 2C and 2D). Serial section analysis and subsequent three-dimensional (3D)-
reconstruction of representative embryos confirmed the regional specificity of the defect, as 
myocardialization of atria, the pulmonary vein, and ventral sinus horns was normal (Figure 2E 
and 2F). 
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Figure 2. Myocardialization defects in the dorsal part of Ctnnb1-deficient sinus horns. A 
through D, Histological and molecular analyses of sinus horns were carried out on transverse 
sections through the venous pole region of E18.5 control and Tbx18cre/+;Ctnnb1fx/fx hearts. Dorsal 
is oriented up. Histological stainings with haematoxylin and eosin (A and B), and in situ 
hybridization analysis of Tnni3 expression (C and D). E and F, Morphological analysis of control 
and Tbx18cre/+;Ctnnb1fx/fx mutant sinus horns by 3D-reconstructions of serial sections stained for 
Tnni3 in a dorsal-posterior view at E17.5. Atrial myocardium is shown in green, sinus horn 
myocardium in grey, the lumen of the caval veins in orange, and the pulmonary vein 
myocardium in red. Arrowheads point to the Tnni3- domain of the left and right cardinal vein. icv, 
inferior caval vein; la, left atrium; lscv, left superior caval vein; lsh, left sinus horn; ppm, 
pleuropericardial membrane; pv, pulmonary vein; ra, right atrium; rscv, right superior caval vein; 
rsh, right sinus horn; SAN, sinoatrial node. 
 
Since Tbx18 is also expressed in the developing SAN of control and conditional Ctnnb1-mutant 
embryos (Figure 3A and 3B),12 we analyzed the consequence of Ctnnb1 deletion for the integrity 
of this tissue. Axin2 was expressed at low levels, rarely above background, in both control and 
Ctnnb1-deficient SAN (Figure 3C and 3D), indicating if present at all, low levels of canonical Wnt 
signaling in this tissue. In E18.5 control embryos, the SAN expressed T-box 3 (Tbx3) and 
hyperpolarization-activated, cyclic nucleotide-gated K+ჼ
 4 (Hcn4). Expression of gap junction 
protein, alpha 5 (Gja5, also known as Cx40) was excluded from the SAN myocardium, but 
detectable in the Tnni3+ myocardialized dorsal part of the right sinus horn, the endothelial cells of 
the SAN artery, and the atria. Tbx3 and Hcn4 expression was unaltered whereas Tnni3 and 
Gja5 expression was almost completely absent in the dorsal part of the right sinus horn in 
Tbx18cre/+;Ctnnb1fx/fx hearts at E18.5 (Online Figure 2) and E17.5 (Figure 3E through 3H). To 
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determine whether the shape and volume of the SAN and right caval vein is altered in mutant 
embryos, we additionally performed serial sectioning and subsequent 3D-reconstruction analysis 
of the Hcn4+ SAN and the Gja5+ region of the right caval vein (Figure 3I through 3K). We 
detected a 93% decrease of the Gja5+ domain in Tbx18cre/+;Ctnnb1fx/fx mice. The lumen of the 
right caval vein and the volume of the SAN were only slightly decreased. The elongated comma-
like structure of the SAN at the entrance to the right atrium was preserved (Figure 3J). We 
conclude that Ctnnb1 and canonical Wnt signaling are dispensable for SAN development, but 
strongly impact on the myocardialization of the dorsal aspect of the sinus horns.  
 
 
Figure 3. Morphology of the SAN in Tbx18cre/+;Ctnnb1fx/fx hearts. A through H, In situ 
hybridization analysis of transverse sections through the SAN of control and Tbx18cre/+;Ctnnb1fx/fx 
hearts for Tbx18 (A and B), the canonical Wnt signaling target Axin2 (C and D), the SAN marker 
Hcn4 (E and F) and the atrial marker Gja5 (G and H). I through K, 3D-reconstructions of the 
lumen of the right superior caval vein (orange), the Hcn4+ SAN (blue), and the Gja5+ myocardium 
of the right sinus horn (red) (I and J), and volume determination of the respective region using 
Amira software (n=1) (K). Note the reduction of the Gja5+ domain. Arrowheads point to the 
dorsal domain of the right sinus horn. Genotypes and stages are as indicated. Abbreviations are 
as in Figure 2. 
 
Sinus horn defects arise early in development 
To determine the onset of sinus horn defects in Tbx18cre/+;Ctnnb1fx/fx hearts, we analyzed 
embryos at earlier developmental stages. Histological analysis at E10.5 (data not shown), E12.5 
and E14.5 revealed that sinus horns were released from the pericardial wall into the pericardial 
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cavity and positioned medially in Tbx18cre/+;Ctnnb1fx/fx similar to control embryos (Figure 4A 
through 4D). In the latter, Tnni3 expression, i.e. myocardialization, was restricted to the most 
ventral aspect of the sinus horn at E10.5 (Online Figure 6C). At E12.5, the Tnni3+ domain in the 
control embryos expanded dorsally, and ensheathed the sinus horns at E14.5 (Figure 4E 
through 4L). In Tbx18cre/+;Ctnnb1fx/fx embryos, myocardialization remained restricted to the 
ventral aspect of the sinus horn at both stages. Hence, myocardialization defects arise shortly 
after E10.5 when Ctnnb1 is lost in the sinus horn lineage.  
 
 
Figure 4. Developmental onset of myocardialization defects in Ctnnb1-deficient sinus 
horns. Haematoxylin and eosin staining (A through D), in situ hybridization analysis of Tnni3 
expression (E through H), and 3D-reconstructions of serial sections stained for Tnni3 in a 
dorsal-posterior view (I through L) of control and Tbx18cre/+;Ctnnb1fx/fx hearts at E12.5 and 
E14.5. Atrial myocardium is shown in green, sinus horn myocardium in grey, the lumen of the 
caval veins in orange, and the pulmonary vein myocardium in red (I through L). Stages and 
genotypes are as indicated. lcv: left cardinal vein; rcv, right cardinal vein; other abbreviations are 
as in Figure 2. 
 
Tbx18+ cells do not exclusively contribute to Ctnnb1-deficient sinus horns 
It is known that Tbx18+ precursors are the source for the sinus horn myocardium in wildtype 
embryos.3 To determine the fate of Tbx18+ precursors in Ctnnb1-deficient sinus horns, we 
introduced an R26mTmG reporter allele into the mutant background. In 
Tbx18cre/+;R26mTmG/+;Ctnnb1fx/+ mice Tbx18cre-expressing cells and their descendants become 
irreversibly labeled by expression of a bright membrane-bound green fluorescent protein (GFP). 
Double immunofluorescence analysis for GFP and the cardiomyocyte marker protein Tnni3 at 
E18.5 confirmed the derivation of the sinus horn myocardium from the Tbx18+ mesenchyme of 
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the caval veins in control (Tbx18cre/+;R26mTmG/+;Ctnnb1fx/+) embryos (Figure 5A through 5C). In 
Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx mutant embryos, the myocardium of the SAN was GFP+ whereas 
the dorsal non-myocardialized region was not derived from Tbx18+ precursors (Figure 5D 
through 5F). To more precisely define the character of this non-myocardialized part of the sinus 
horns, we expanded our immunohistochemical analysis. In control hearts the myo-fibroblast 
marker fibronectin 1 (Fn1) was not detectable in the Tbx18-derived sinus horn myocardium but 
was expressed in the pleuropericardial membrane and the adjacent tissue next to the dorsal 
mesocardium (Figure 5G through 5I). However, the GFP- region of the right sinus horn in 
Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx embryos stained for Fn1 as well as for actin, alpha 2, smooth 
muscle, aorta (Acta2) (Figure 5J through 5L, 5P through 5R). In the wildtype control, Acta2 was 
expressed in vascular smooth muscle cells13 but not in the sinus horns (Figure 5M through 5O). 
Moreover, we verified the nearly complete loss of Gja5 in Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx sinus 
horns by double immunofluorescence analysis for GFP and Gja5 (Online Figure 3A through 3F). 
Expression of the conduction system marker Tbx3, and the mesothelial marker Wilms tumor 1 
homolog (Wt1) was unchanged in the mutant sinus horns, confirming the sinus horn specific 
defects after Tbx18cre mediated inactivation of Ctnnb1 (Online Figure 3G through 3R). In 
conclusion, the dorsal region of Ctnnb1-deficient sinus horns is composed of myofibroblasts that 
derive from sources other than Tbx18+ precursors.  
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Figure 5. Cellular contributions to the Ctnnb1-deficient systemic venous return of the 
heart. A through R, Comparative immunofluorescence analysis of cellular derivates of the 
Tbx18+ domain of the sinus horns, marked by GFP expression, and cardiac troponin Tnni3 (A 
through F), the fibroblast marker Fn1 (G through H) or the smooth muscle marker Acta2 (M 
through N) in control (genotype: Tbx18cre/+;R26mTmG/+;Ctnnb1fx/+) and 
Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx mutant sinus venosus region of the heart at E18.5. Antibodies 
and genotypes are as indicated, nuclei are counterstained with DAPI. Arrowheads mark the 
Tnni3- part of the Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx mutant right sinus horns. rsh; right sinus horn; 
SAN, sinoatrial node. 
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Molecular analysis of Ctnnb1-deficient sinus horns 
We next analyzed by in situ hybridization analysis whether the observed defects in the Ctnnb1-
deficient sinus horns are accompanied by altered expression of factors or pathways associated 
with regionalization and differentiation of the posterior cardiac pole. Expression of marker genes 
for the FHF (Nkx2-5) and the SHF (Tbx1, Isl1, and Fgf10) was absent from wildtype and mutant 
sinus horns at E12.5. Tbx5 was expressed in the atria and sinus horns of both wildtype and 
Ctnnb1-deficient mice (Online Figure 4A through 4J). The Fgf signaling pathway promotes 
proliferation in the anterior SHF and is important for the development of the OFT,14 but Fgf8 and 
Fgf10 as well as its target genes15 ets variant gene 4 (Etv4, also known as Pea3) or Etv5 (also 
known as Erm) were not detectable in control or Tbx18cre/+;Ctnnb1fx/fx sinus horns (Online Figure 
4I through 4L, and data not shown). Since the bone morphogenetic protein (Bmp) signaling 
pathway is crucial for the differentiation of cardiomyocytes in the OFT,16 we additionally analyzed 
the expression of Bmp2 and Bmp4, as well as its target genes homeobox, msh-like 1 (Msx1) and 
Msx2, in the developing sinus horns at E12.5. Bmp2 and Bmp4 expression was detectable in the 
SAN tail, which is located in the sinus venosus, in both control and Ctnnb1-deficient mice 
(Online Figure 4M through 4R, and data not shown).17 Loss of sonic hedgehog (Shh) signaling in 
Isl1-positive cardiac progenitors leads to OFT defects.18 Expression of Shh and its target gene 
patched homolog 1 (Ptch1) were unverifiable in the intrapericardial domain of the wildtype and 
mutant sinus horns at E12.5 (Online Figure 4S and 4T, and data not shown). A feed-forward 
loop between the Wnt ligand Wnt2 and the GATA binding protein 6 (Gata6) is important for 
proliferation of SHF progenitors of the heart and, hence, for the development of the atria and the 
AVC.6 We detected expression of Wnt2 and Gata6 in the developing sinus horns at E14.5 in 
both wildtype and mutant embryos (Online Figure 5A through 5D). Similarly, Sfrp1 expression 
was unchanged, excluding a self-regulation of Wnt/Ctnnb1 signaling in this region (Online Figure 
5E and 5F). Furthermore, loss of Ctnnb1 did not affect expression of markers of the 
pleuropericardial membrane and its underlying mesenchyme including Sfrp2, Wt1, and aldehyde 
dehydrogenase family 1, subfamily A2 (Aldh1a2) (Online Figure 5G through 5L).19 In conclusion, 
these results again demonstrate the distinct molecular signature of the developing sinus horns 
and the SAN. We could not reveal a role of Bmp, Fgf and Shh signaling during sinus horn 
development. Loss of Ctnnb1 does not affect regionalization and precursor contribution at the 
posterior cardiac pole. 
 
Ectopic activation of canonical Wnt signaling in the developing sinus horns  
To further clarify the role of Ctnnb1-dependent Wnt signaling during sinus horn development, we 
employed a gain-of-function approach with conditional (Tbx18cre-mediated) overexpression of a 
stabilized form of Ctnnb1 (Ctnnb1(Ex3)fl)9 (Figure 6).  
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Figure 6. Ectopic activation of canonical Wnt signaling in the sinus venosus region 
induces cell clusters. (A and B) Haematoxylin and eosin staining, and (C through L) in situ 
hybridization analysis on transverse sections for the Wnt target gene Axin2 (C and D), the sinus 
horn marker gene Tbx18 (E and F), the SAN marker genes Tbx3 and Shox2 (G trough J), and 
the cardiomyocyte markerTnni3 (K and L) in control and Tbx18cre/+;Ctnnb1(Ex3)fl/+ mutant cardiac 
venous pole region at E12.5. Genotypes are as indicated. Arrowheads point to the ectopic cell 
clusters in the Tbx18cre/+;Ctnnb1(Ex3)fl/+ sinus venosus region. la, left atrium; lcv, left cardinal vein; 
lu, lung; lv, left ventricle; ra; right atrium; rcv, right cardinal vein; SAN, sinoatrial node; vv, venous 
valves.  
 
Tbx18cre/+;Ctnnb1(Ex3)fl/+ embryos died during midgestation due to cardiovascular insufficiencies 
(to be described in full detail somewhere else). Histological inspection of surviving embryos at 
E12.5 revealed the presence of large cell aggregates in the developing sinus horns of 
Tbx18cre/+;Ctnnb1(Ex3)fl/+ mutant embryos (Figure 6A and 6B). Strong Axin2 expression confirmed 
activation of canonical Wnt signaling in these cell clusters (Figure 6C and 6D). Expression of the 
regional marker genes Tbx18, Tbx3 and short stature homeobox 2 (Shox2) was present, 
whereas cardiomyocyte marker expression (Tnni3) was absent from these cell aggregates 
(Figure 6E through 6L). Inspection of earlier developmental stages revealed presence of small 
cell aggregates from E10.5 onwards. Expression of Etv5, a target gene of the Fgf signaling 
pathway, which is known to promote proliferation in SHF progenitors, was found in the outer 
layers of these clusters. Also the expression of cyclinD1 (Ccnd1), a direct Wnt target gene and 
positive regulator of cell cycle progression, was detectable in these cell clusters (Online Figure 6 
and 7). We conclude that sinus horn specific expression of a stabilized form of Ctnnb1 results in 
formation of aggregates composed of mesenchymal precursor cells, which were not able to 
differentiate into cardiomyocytes. 
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Cellular changes in the Tbx18-positive region of the developing sinus horns 
We next investigated whether changes in proliferation and apoptosis may underlie the observed 
lack of cardiomyocytes in the dorsal aspects of Tbx18cre/+;Ctnnb1fx/fx sinus horns. The BrdU 
incorporation assay revealed decreased proliferation of Tbx18 expressing sinus horn precursor 
cells between E10.5 and E14.5 (Figure 7D, Online Figure 8), reaching significant values at 
E10.5 (wildtype 0.274±0.0183 vs mutant 0.217±0.0341; P=0.042) and E14.5 (wildtype 
0.173±0.0197 vs mutant 0.100±0.0254; P=0,018), but not at E12.5 (wildtype 0.208±0.0252 vs 
mutant 0.181±0.0116; P=0.175). Apoptosis was not increased in the sinus horns in any of these 
stages (data not shown) suggesting that decreased proliferation contributes to the observed 
defects in mutant embryos.  
Since we noted an increasing size of the cell clusters in the Tbx18cre/+;Ctnnb1(Ex3)fl/+ embryos 
from E10.5 to E12.5, we also analyzed cell proliferation and apoptosis in these mutant mice. At 
E10.5, the proliferation in the Tbx18+ cell aggregates was highly and significantly increased 
(control 0.167±0.0390 vs mutant 0.437±0.0275; P=0.002). At E11.5, proliferation rates 
decreased in control and mutant clusters but were maintained at a significantly higher level in 
the mutant (control 0.190±0.0300 vs mutant 0.235±0.0675; P<0.001) (Figure 7E and Online 
Figure 9). At E10.5, low levels of apoptosis was observed in Tbx18+ cell aggregates, but not in 
the cardinal veins of both control and gain-of-function embryos (we analyzed three control and 
three Tbx18cre/+;Ctnnb1(Ex3)fl/+-mutant embryos). At E11.5 and E12.5, the whole center of these 
cell aggregates became largely apoptotic (we analyzed two embryos of each genotype), 
whereas apoptosis was not detectable in control embryos (Online Figure 10). Hence, canonical 
Wnt signaling is required and sufficient to maintain proliferation of mesenchymal precursor cells 
of the sinus horn myocardium.  
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Figure 7. Cellular changes in Ctnnb1-deficient sinus horns and in ectopic aggregates of 
Tbx18cre/+;Ctnnb1(Ex3)fl/+ sinus horns. A through C, Analysis of proliferation by BrdU 
immunohistochemistry in the red encircled, Tbx18+ intrapericardial domain of the sinus horns 
performed on transverse sections through the posterior systemic venous return at E10.5. BrdU 
positive cells are labeled in green, nuclei are counterstained with DAPI. D and E, Proliferation 
rates (% BrdU labeling index) of red encircled regions in genotypes and stages as shown. D, 
The P-values in the Ctnnb1-deficient sinus horns are P=0.042 (*) at E10.5, P=0.175 (not 
significant) at E12.5 and P=0,018 (**) at E14.5. E, The P-values in the Tbx18cre/+;Ctnnb1(Ex3)fl/+ 
mutant systemic venous return including the ectopic cell aggregates are P= 0.2637 (ns) at E9.5, 
P= 0,002 (**) at E10.5 and P<0,001 (***) at E12.5. lu, lung, rcv, right cardinal vein.  
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Discussion  
 
The myocardial sleeves of the superior and inferior caval veins and the SAN myocardium 
derives from a distinct Tbx18+Nkx2-5- mesenchymal precursor cell population. Here, we have 
shown that canonical Wnt signaling is required for the myocardialization of the dorsal domain of 
the developing sinus horns. Forced Wnt signaling is sufficient to induce high proliferation and 
prevent the differentiation into cardiomyocytes in this region. We suggest that Ctnnb1-dependent 
Wnt signaling in the intrapericardial domain of the developing caval veins is part of a signaling 
system that balances proliferation and cardiomyocyte differentiation of these mesenchymal 
precursor cells. 
 
A regionalized requirement for canonical Wnt signaling in sinus horn development 
The general significance of canonical Wnt signaling in heart development has been shown in 
previous studies.1,20 Conditional loss of Ctnnb1 in the early mesodermal progenitors of both the 
FHF and SHF revealed that Ctnnb1-dependent Wnt signaling does not affect cardiac crescent 
formation, which derives from the FHF, but is required for the development of SHF derived 
structures and cardiac looping.21 Wnt2 has been identified as a canonical ligand acting in the 
Nkx2-5+Isl+ inflow tract mesoderm to regulate addition of atria and AVC to the posterior pole of 
the growing heart tube.6,22  
Our analysis of the expression of Wnt pathway components and the function of Ctnnb1 expands 
the role of canonical Wnt signaling to sinus horn formation. Deletion of Ctnnb1 from the sinus 
venosus lineage results in a specific lack of myocardialization in the dorsal aspects of the sinus 
horns. However, loss of Ctnnb1 does not affect formation of the SAN that also derives from a 
Tbx18+ cell lineage. Although the SAN considerably expands between E10.5 and E14.5, 
increase in size may not rely on recruitment and myocardialization of mesenchymal precursor 
cells but may occur by division of primitive cardiomyocytes that are specified early to a SAN sub-
lineage. Evidence is provided by the distinct molecular character of the developing SAN 
including the expression of Tbx3, Shox2, Hcn4 and Bmp signaling components. Although Tbx3 
was discussed as a target of canonical Wnt signaling in cancer, unaltered expression in the 
Tbx18cre/+;Ctnnb1fx/fx sinus venosus argues for a different regulation in this developmental 
context.  
Ctnnb1 is not only the transcriptional effector of the canonical Wnt signaling pathway, but 
additionally is a key molecule in adherens junctions.23,24 Nevertheless, its close relative 
plakoglobin, also known as gamma-catenin, can compensate the loss of beta-catenin in Ctnnb1-
deficient embryos23 as well as in adult cardiomyoctes.24 In Ctnnb1 loss-of-function mutants 
adherens junctions developed, and the cell morphology remained unchanged. Therefore, we 
conclude that the defects described in the Tbx18cre/+;Ctnnb1fx/fx mutant sinus horns are mainly 
due to the loss of Ctnnb1 as a signaling molecule.  
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Support for a role of canonical Wnt signaling in the developing sinus horns is provided by 
expression of Wnt ligands and receptors, and most importantly by expression of Axin2 that has 
been described as a bona fide target of this pathway. Loss of expression of Axin2 from the 
intrapericardial domain of the sinus horns after Tbx18cre-mediated deletion of Ctnnb1 function 
and strong induction of Axin2 expression after stabilization of Ctnnb1 in this domain confirms the 
character of Axin2 as a target of Ctnnb1 for the development of the dorsal aspect of the sinus 
horns and proves the efficiency of our genetic approach to manipulate canonical Wnt signaling. 
Our Wnt expression screen argues that canonical Wnt signaling in the developing sinus horns is 
mediated by Wnt2 and Wnt10a ligands and the Fzd7 receptor. Wnt signaling may be modulated 
(diminished) by sFRP1 that binds the ligands and prevents activation of the pathway.  
In the posterior SHF, Wnt2 works in a feed-forward transcriptional loop with Gata6 to regulate 
atria and AVC development.6 Wnt2 as well as Gata6 expression were unchanged in the 
Tbx18cre/+;Ctnnb1fx/fx sinus horns, suggesting that Wnt signaling in the “third heart field” employs 
different downstream mediators compared to the SHF. The analysis of additional signaling 
pathways further emphasizes the distinct character of the Tbx18+Nkx2-5- precursor pool. The 
Bmp, Fgf and Shh signaling pathways are important for the development of SHF-derived 
structures, especially the OFT region of the murine heart.1 However, none of the analyzed 
components or target genes of these pathways were detectable in the developing sinus horns, 
nor were they de-repressed in Ctnnb1-deficient sinus horns.  
 
Canonical Wnt signaling maintains proliferation of mesenchymal precursor cells 
We have recently shown that the myocardialized proximal aspects of the superior and inferior 
caval veins form only after heart cardiac looping by recruitment and subsequent myocardial 
differentiation of Tbx18+ pericardial precursors.3 The lack of myocardium in the dorsal aspect of 
the sinus horns of Ctnnb1-deficient embryos can therefore be explained in at least two ways. 
Canonical Wnt signaling may promote the expansion of the mesenchymal precursor pool or 
additionally/alternatively direct the differentiation of these progenitors into cardiomyocytes.  
In Ctnnb1-deficient sinus horns, cell proliferation was significantly reduced as early as E10.5 
suggesting that the progenitor pool was strongly and quickly diminished. This is supported by the 
lineage analysis in these mutants that revealed that the Tbx18+ sinus venosus progenitors do 
not contribute to the myofibroblastic tissue in the dorsal domain. Furthermore, forced activation 
of canonical Wnt signaling by a stabilized form of Ctnnb1 leads to hyperproliferative cell 
aggregates which express regional marker genes including Tbx18 but fail to differentiate into 
cardiomyocytes.  
Together, these findings strongly argue that canonical Wnt signaling maintains the sinus horn 
precursor pool. A similar mode of action was described for Wnt2 function in the posterior SHF 
and goes along the general line of Wnt signaling as a positive regulator of the cell cycle.20,25 Not 
surprisingly, we found activation of Ccnd1 expression, a direct Wnt target gene and positive 
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regulator of cell cycle progression, in the cell aggregates expressing stabilized Ctnnb1 in the 
sinus horns. Increased levels of canonical Wnt/Ctnnb1 signaling were also found to be sufficient 
to induce Fgf signaling that has been associated with increased cell proliferation in many other 
contexts. It remains unclear whether Fgf signaling represents an non-physiological response to 
enhanced Wnt signaling since we did not detect expression of the Fgf target gene Etv5 in the 
wildtype sinus horns.  
Our molecular analysis in the myocardium of the sinus horns did not detect Bmp signaling, a 
known promoter of cardiomyocyte differentiation. It therefore remains to be deciphered what 
other signaling pathway(s) counteract Wnt signaling to promote myocardial differentiation during 
sinus horns development. 
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Supplemental Online Materials and Methods 
 
Mice and genotyping 
Mice with a knock-in of the cre recombinase gene into the Tbx18 locus (Tbx18tm4(cre)Akis, 
synonym: Tbx18cre),1 mice with two loxP sites flanking the Ctnnb1 locus from exon 2 to exon 6 
(Ctnnb1tm2Kem, synonym: Ctnnb1fx),2 mice with two loxP sites flanking exon 3 of the Ctnnb1 locus 
(Ctnnb1tm1Mmt, synonym: Ctnnb1(Ex3)fl),3 and the fluorescent reporter line (Gt(ROSA)26Sortm4(ACTB-
tdTomato,-EGFP)Luo/J, synonym: R26mTmG)4 were all described before. All lines were maintained on an 
outbred (NMRI) background. The sinus horns specific Ctnnb1 loss-of-function mutants 
(Tbx18cre/+;Ctnnb1fx/fx and Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx) were obtained from matings of 
Tbx18cre/+;Ctnnb1fx/+ and Tbx18cre/+;R26mTmG/+;Ctnnb1fx/+ males, respectively, with Ctnnb1fx/fx 
(Ctnnb1tm2Kem)2 females. Sinus horns specific Ctnnb1 gain-of-function mice 
(Tbx18cre/+;Ctnnb1(Ex3)fl/+ and Tbx18cre/+;R26mTmG/+;Ctnnb1(Ex3)fl/+) were derived from matings of 
Tbx18cre/+ and Tbx18cre/+;R26mTmG/+ males, respectively, with Ctnnb1(Ex3)fl/(Ex3)fl (Ctnnb1tm1Mmt)3 
females. 
Vaginal plugs were checked in the morning after mating, for timed pregnancies noon was taken 
as embryonic day (E) 0.5. After harvesting the embryos in PBS, they were fixed in 4% 
paraformaldehyde overnight and stored in 100% methanol at –20oC before further use. For the 
analysis of the conditional Ctnnb1 loss-of-function phenotype, heterozygous animals 
(Tbx18cre/+;Ctnnb1fx/+) were used as control embryos. For the Ctnnb1 gain-of-function analysis 
Tbx18+/+;Ctnnb1(Ex3)fl/+ embryos were used as control. Genomic DNA prepared from yolk sacs or 
tail biopsies was used for genotyping by PCR (protocols upon request). H. Hedrich, state head 
of the animal facility, approved the care of animals and experiments at Medizinische Hochschule 
Hannover. 
 
Histological analysis  
For histological stainings embryos were fixed overnight in 4% paraformaldehyde, paraffin 
embedded, and sectioned to 10-µm. Sections were stained with haematoxylin and eosin, 
following standard procedures. At least two embryos of each genotype were used for each 
analysis.  
 
In situ hybridization analysis  
Nonradioactive in situ hybridization analysis with digoxigenin-labeled antisense riboprobes was 
performed as described.5 At least two embryos of each genotype were used for each analysis. 
Details of used probes upon request. 
 
Documentation 
Sections were photographed using a Leica DM5000 microscope with Leica DFC300FX digital 
camera and afterwards processed in Adobe Photoshop CS3. 
 
Three-dimensional reconstruction 
For three-dimensional visualization and geometry reconstruction 10-µm serial sections of the 
whole heart of representative embryos of each genotype were used for in situ hybridization and 
documented as described. Further analysis was performed using the software “Amira” (Version 
4.1.1, Mercury Computer Systems Inc) as described previously.6 After documentation, the 
pictures were aligned, and regions for reconstruction were labeled. A three-dimensional model 
was obtained after surface conversion. Based on this reconstruction the volume of the different 
labels was calculated by the software “Amira”.  
Immunohistochemistry 
For immunofluorescence analysis, mouse monoclonal antibody against GFP (1:250, 
11814460001, Roche), mouse monoclonal antibody against Fn-1 (1:300, F7387, Sigma), mouse 
monoclonal antibody against Acta2, FITC conjugate (1:250, F3777, Sigma), goat polyclonal 
antibody against Tbx3 (1:200, sc-31656, Santa-Cruz), rabbit polyclonal antibody against Gja5 
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(1:50, AB1726, Millipore), goat monoclonal antibody against Tnni3 (1:300, 4T21/2, HyTest), and 
rabbit polyclonal antibody against Wt1 (1:400, C-19, Santa Cruz Biotechnology) were used as 
primary antibodies.  
Alexa488 goat-anti-rabbit (1:250, Invitrogen), Alexa488 donkey-anti-mouse (1:250, Invitrogen), 
biotinylated goat-anti-rabbit (1:250, 111-065-003, Dianova) and biotinylated donkey-anti-goat 
(1:250, 705-065-003, Dianova) were used as secondary antibodies. Nuclei were stained with 
4',6-diamidino-2-phenylindol (DAPI) (Roth). All used paraffin sections were pressure cooked for 
3 min in antigen unmasking solution (H-3300, Vector Laboratories Inc). Endogenous peroxidase 
activity was blocked by 3% H2O2. The signal was amplified using either the Tyramide Signal 
Amplification (TSA) system from Perkin-Elmer (NEL702001KT, Perkin Elmer LAS) or the 
Mouse-on-mouse (M.O.M.) immunodetection kit from Vector Laboratories (PK-2200, Vector 
Labs). The anti-GFP staining was performed in a second experiment directly after the first 
immunodetection was finished and followed the published protocols. 
 
Proliferation and apoptosis assays  
Cell proliferation in E9.5 to E14.5 embryos was investigated by detection of incorporated 5-
bromo-2-deoxyuridine (BrdU) on 5-µm sections of paraffin-embedded specimens similar to 
previously published protocols.7 Wildtype littermates were used as controls for each genotype 
and stage. Both the left cardinal vein and right cardinal veins were counted. For analysis of 
Tbx18cre/+;Ctnnb1fx/fx hearts, five sections each of four embryos of each genotype at E10.5, and 
five sections each of three embryos of each genotype at E12.5 and E14.5 were used for 
quantification. The quantification of proliferation in Tbx18cre/+;Ctnnb1(Ex3)fl/+ and control hearts was 
performed with six sections each of four embryos of each genotype at E9.5, and six sections of 
each of three embryos of each genotype and stage at E10.5 and E11.5. The BrdU-labeling index 
was defined as the number of BrdU-positive nuclei relative to the total number of nuclei, as 
detected by DAPI counterstain, in the Tbx18 expressing region of the left and right cardinal 
veins. Statistical analyses were performed using the 2-tailed Student’s t-test. Data were 
expressed as mean ± SEM. Differences were considered not significant when the P-value was 
higher than 0.05, significant (*) when the P-value was below 0.05, highly significant (**) when 
the P-value was below 0.01, and extremely significant (***) if P<0.001. 
Detection of apoptotic cells on 10-µm paraffin sections of wildtype and Tbx18cre/+;Ctnnb1(Ex3)fl/+ 
mutant embryos was based on modification of genomic DNA utilizing terminal deoxynucleotidyl 
transferase (TUNEL assay) and indirect detection of positive cells by fluorescein-conjugated 
anti-digoxigenin antibody. The procedure followed the recommendation of the manufacturer 
(Serologicals Corp.) of the ApopTag kit used. Four sections each of three embryos of each 
genotype at E10.5, E11.5, and E12.5 were analyzed.  
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Supplemental Online Figures 
 
 
 
Online Figure 1. Wnt signaling in sinus horn development. In situ hybridization analysis on 
transverse sections through the venous pole region for expression of Wnt pathway components 
Wnt2, Wnt10a, Fzd7 and Sfrp1 (A through D), and of Axin2 and Tbx18 (E and F) in wildtype 
embryos at E10.5. Arrowheads point to the intrapericardial components of the left and right 
cardinal vein. Probes are as indicated. lcv, left caval vein; ra, right atrium; rcv, right caval vein. 
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Online Figure 2. Absence of the Gja5+ myocardium in the dorsal domain of the right sinus 
horn in Tbx18cre/+;Ctnnb1fx/fx hearts. A through H, In situ hybridization analysis for SAN 
expression of Tbx3, Hcn4, cardiomyocyte specific Tnni3, and Gja5 in E18.5 hearts of control 
(left column) and Tbx18cre/+;Ctnnb1fx/fx (right column) embryos on transverse sections trough 
the base of the caval vein. Arrowheads point to the Tnni3- domain of the right sinus horn. rsh, 
right sinus horn; SAN, sinoatrial node. 
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Online Figure 3. Cellular contribution to systemic venous return in E18.5 embryos with 
conditional deletion of Ctnnb1. A through R, Comparative immunofluorescence analysis on 
transverse sections through the sinus venosus region of control (genotype: 
Tbx18cre/+;R26mTmG/+;Ctnnb1fx/+) and Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx mutant hearts. Cellular 
derivates of the Tbx18+ domain of the sinus horns are marked by GFP expression and 
compared to the gap junction protein Gja5 (A through F), the conduction system marker Tbx3 
(G through L) and the mesothelial marker Wt1 (M through R). Arrowheads mark the Tnni3- part 
of the Tbx18cre/+;R26mTmG/+;Ctnnb1fx/fx mutant right sinus horns. Genotypes are as indicated. rsh, 
right sinus horn.  
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Online Figure 4. Analysis of FHF and SHF marker genes and signaling pathways in 
Ctnnb1-deficient sinus horns. A through T, In situ hybridization analysis of the FHF marker 
genes Nkx2-5 and Tbx5 (A through D), the SHF genes Tbx1, Isl1 and Fgf10 (E through J), the 
target of Fgf signaling Etv5 (K and L), the Bmp signaling components Bmp2, Bmp4 and its 
target gene Msx1 (M trough R) and the Shh signaling target gene Ptch1 (S and T) on 
transverse sections through the systemic venous return of control (genotype: 
Tbx18cre/+;Ctnnb1fx/+) and Tbx18cre/+;Ctnnb1fx/fx mutant embryos at E12.5. Probes and genotypes 
are as indicated. lcv, left caval vein; ra, right atrium; rcv, right caval vein. 
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Online Figure 5. Analysis of molecular changes in the Tbx18cre/+;Ctnnb1fx/fx venous pole 
region of the heart. A through L, In situ hybridization analysis of the Wnt ligand Wnt2 (A and 
B), Gata6 (C and D), the Wnt antagonists Sfrp1 (E and F) and Sfrp2 (G and H), and the 
mesothelial marker genes Wt1 (I and J) and Aldh1a2 (K and L) on transverse sections through 
the systemic venous return of control and Tbx18cre/+;Ctnnb1fx/fx mutant embryos at E14.5. Probes 
and genotypes are as indicated. Arrowheads mark gene expression in the intrapericardial 
domain of the caval veins. la, left atrium; lscv, left superior caval vein; ppm, pleuro-pericardial 
membrane; ra, right atrium, rscv, right superior caval vein. 
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Online Figure 6. Ectopic cell aggregates in Tbx18cre/+;Ctnnb1(Ex3)fl/+ mutant sinus horns are 
detectable at E10.5. A through H, In situ hybridization analysis on transverse sections for the 
canonical Wnt signaling target gene Axin2 (A and B), the cardiomyocyte marker Tnni3 (C and 
D), the target gene of Fgf signaling Etv5 (E and F) and the direct Wnt target gene and positive 
regulator of cell cycle progression Ccnd1 (G and H) in the venous pole region of control (left 
column, genotype: Tbx18+/+;Ctnnb1(Ex3)fl/+) and Tbx18cre/+;Ctnnb1(Ex3)fl/+ mutant (right column) 
hearts at E10.5. The arrow points to the Tnni3+ ventral domain of the right sinus horn. 
Arrowheads highlight the ectopic cell clusters in Tbx18cre/+;Ctnnb1(Ex3)fl/+ sinus venosus region. 
lcv, left cardinal vein; rcv, right cardinal vein. 
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Online Figure 7. Developmental onset of ectopic cell aggregate formation in the 
Tbx18cre/+;Ctnnb1(Ex3)fl/+ sinus venosus region of the heart. A through J, In situ hybridization 
analysis on transverse sections for the Wnt target gene Axin2 (A and B), the sinus horn marker 
gene Tbx18 (C and D), the cardiomyocyte marker Tnni3 (E and F), the target gene of Fgf 
signaling Etv5 (G and H), and the direct Wnt target gene and positive regulator of cell cycle 
progression Ccnd1 (I and J) in the venous pole region in control (left column) and 
Tbx18cre/+;Ctnnb1(Ex3)fl/+ (right column) embryos at E11.5. Arrowheads point to the ectopic cell 
aggregates in the mutant sinus venosus region. lcv, left cardinal vein; rcv, right cardinal vein. 
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Online Figure 8. Cellular changes in Ctnnb1-deficient sinus horns. A through F, Analysis of 
proliferation in the red encircled, Tbx18+ intrapericardial domain of the sinus horns performed on 
transverse sections through the posterior systemic venous return by BrdU 
immunohistochemistry. BrdU positive cells are labeled in green, nuclei are counterstained with 
DAPI. lcv, left cardinal vein; lsh, left sinus horn; rcv, right cardinal vein.  
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Online Figure 9. Increased cell proliferation in ectopic aggregates of 
Tbx18cre/+;Ctnnb1(Ex3)fl/+ sinus horns. A through F, Analysis of cell proliferation in the red 
encircled, Tbx18+ intrapericardial domain of the sinus horns in control hearts and the 
corresponding intrapericardial domain of the sinus horns in Tbx18cre/+;Ctnnb1(Ex3)fl/+ mutant 
systemic venous return including the ectopic cell aggregates by BrdU immunohistochemistry. 
BrdU positive cells are labeled in green, nuclei are counterstained with DAPI. lu, lung; other 
abbreviations are as in Online Figure 8. 
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Online Figure 10. Apoptosis is detectable in the ectopic cell aggregates in the sinus 
venosus region of Tbx18cre/+;Ctnnb1(Ex3)fl/+ hearts at different embryonic stages. A through 
F, Analysis of apoptosis in control (A through C) and Tbx18cre/+;Ctnnb1(Ex3)fl/+ (D through F) sinus 
horns. Stages are as indicated. White arrows mark the mutant cell aggregates. lcv, left cardinal 
vein; lu, lung; rcv, right cardinal vein.  
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Concluding remarks 
 
This study contributes significant new insides into the processes that are involved in the 
development of the cardiac venous pole and its mesothelial lining. I demonstrate that sinus horn 
and pericardial development are coupled and that both depend on Wt1 and downstream retinoic 
acid signaling (part 1) as well as on canonical Wnt/beta-catenin signaling (part 3 and 4). 
Furthermore, this work includes the first characterization of the mechanisms involved in murine 
pericardial development and identifies the T-box transcription factor Tbx18 as a crucial gene 
partly regulating these processes (part 2).  
This work illustrates that two independent steps are essential for the development of a complete 
pericardium. On the one hand, the pleuropericardial membranes detach from the lateral body 
wall, a process that requires the disintegration of the subcoelomic mesenchyme. I discovered 
important factors (Wt1 and retinoic acid signaling, canonical Wnt signaling) regulating the loss of 
the subcoelomic mesenchyme and the associated increase of the pleural cavity. However, most 
of the genetic circuit that regulates the disappearance of the subcoelomic mesenchyme is still 
unidentified. In a comparable cavitation process during middle ear development apoptosis is 
partly responsible for the loss of mesenchymal cells, but most of these mesenchymal cells are 
reallocated over the increasing surface of the growing cavity.(34,35) Throughout the analysis of 
Wt1-deficient embryos, I also detected low rates of apoptosis in the subcoelomic mesenchyme 
of wildtype embryos which was specifically lost in Wt1-deficient embryos. Further work will 
concentrate on the quantification of apoptosis, and the characterization of the fate of these 
subcoelomic mesenchymal cells by lineage tracing experiments. Additionally, I will enforce the 
identification of genes that regulate the fate of these mesenchymal cells and the 
pleuropericardial membranes. A first approach by a gene expression screen in the subcoelomic 
mesenchyme and the developing pleuropericardial membranes was already performed, and its 
results may point to the direction of prospective experiments.  
A second mechanism that is involved in pericardial development is the closure of the 
pleuropericardial ducts by a Tbx18-positive mesenchymal protrusion within these canals. I 
conclude that the closure of the pleuropericardial ducts is partly required for the medial 
positioning of the caval veins next to the hilus of the lung. In the absence of sinus horn 
attachment to their medial fixation point, the tensile force of the increasing embryonic size onto 
the pleuropericardial membranes leads to the their lateral positioning. This tension might also be 
partly essential for the detachment of the pleuropericardial membranes from the lateral body 
wall, a mechanism that was already proposed for human pericardial development,(11) but neither 
cellular nor genetically analyzed. Therefore, the underlying mechanisms need to be further 
examined, as molecular insides into these processes are unidentified so far.  
In Wt1-deficient embryos the sinus horns are positioned laterally within the persisting 
subcoelomic mesenchyme and not myocardialized. At this time I speculated that a medial 
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positioning of the sinus horns next to the hilus of the lung and thus to sources of differentiation 
signals is a prerequisite for their myocardialization. However, my analysis in conditional beta-
catenin gain- and loss-of-function embryos questioned my earlier statements, as the caval veins 
are myocardialized although they are embedded in a persisting subcoelomic mesenchyme. 
However, in addition to the known significance of Tbx18 for the myocardialization of the sinus 
horns, my analysis demonstrated the importance of canonical Wnt signaling specifically in the 
Tbx18-positive domain of the sinus horn for their myocardialization. In this specific domain of the 
sinus horns the beta-catenin mediated Wnt signaling pathway is required to maintain the 
proliferation of progenitor cells. Also in general, canonical Wnt/beta-catenin signaling is known to 
be important for precursor cell proliferation and additionally it inhibits the terminal differentiation 
of these cells in various developmental processes, one of them is the elongation of the heart 
tube by the progenitor cells of the second heart field.(20) Whether this signaling pathway has a 
similar function in pericardial development remains unanswered so far. 
 
Recent publications emphasized the evolutionary conservation of genetic mechanisms 
regulating embryonic cardiac development.(36) In both human and murine venous pole 
development the myocardialized caval veins are positive for Tbx18 and negative for Nkx2-5 
expression. Furthermore, human pericardial development is described as an active ingrowth of 
two pleuropericardial folds, which will form the pleuropericardial membranes and later the 
mature pericardium.(37) I was not able to verify an active ingrowth of two folds into the 
pleuropericardial ducts during murine pericardial development. In my opinion this interpretation 
of human pericardial development may be the result of limited human embryonic material 
available. The genetic background of human pericardial defects is completely missing at the 
moment, but a sporadic familiar accumulation of this defect points to inherited genetic defects.(38) 
Future analysis might reveal more similarities between murine and human cardiac development, 
therefore my research in this so far insufficiently examined region of the heart will continue.  
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